aspirin has been researched along with Complications, Pregnancy in 368 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 9.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
| "The EAGeR trial randomly assigned 1228 women with a history of pregnancy loss to receive 81 mg aspirin or placebo for up to six menstrual cycles of attempting pregnancy and, if they became pregnant, throughout pregnancy." | 9.30 | Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes. ( Hill, M; Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2019) |
| " It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia." | 9.24 | Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. ( Akolekar, R; Cicero, S; de Paco Matallana, C; Gizurarson, S; Janga, D; Jani, JC; Maclagan, K; Meiri, H; Molina, FS; Nicolaides, KH; O'Gorman, N; Papaioannou, G; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Singh, M; Syngelaki, A; Tenenbaum-Gavish, K; Wright, D, 2017) |
| "The objective of the study is to evaluate low-dose aspirin (LDA) for pre-eclampsia prevention in twin gestations with elevated maternal serum human chorionic gonadotropin (hCG)." | 9.22 | Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin. ( Allshouse, AA; Euser, AG; Heyborne, KD; Metz, TD, 2016) |
| "Aspirin supplementation was associated with worse outcomes related to preterm birth in smokers in a high-risk but not low-risk cohort." | 9.20 | Low-dose aspirin, smoking status, and the risk of spontaneous preterm birth. ( Abramovici, A; Biggio, J; Cantu, J; Edwards, R; Jauk, V; Tita, A; Wetta, L, 2015) |
| "To evaluate the effect of low-dose aspirin in prevention of adverse pregnancy outcomes (APO) in women with second trimester alpha-fetoprotein (AFP) >2." | 9.19 | Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein. ( Alavi, A; Borna, S; Hantoushzadeh, S; Khazardoost, S; Khezerlou, N; Mousavi, S, 2014) |
| "Preconception-initiated low-dose aspirin might positively affect pregnancy outcomes, but this possibility has not been adequately assessed." | 9.19 | Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. ( Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Silver, RM; Townsend, JM; Wactawski-Wende, J, 2014) |
| "Aspirin desensitization may be a safe alternative even during pregnancy if carefully monitored and permit patients with APS to receive treatment with ASA." | 9.12 | Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients. ( Alijotas-Reig, J; Cisteró-Bahíma, A; San Miguel-Moncín, M, 2006) |
| " Aspirin (75 mg daily) was commenced at the time of a positive pregnancy test and heparin (5000 units subcutaneously 12 hourly, or enoxaparin 20 mg daily) was started when fetal heart activity was demonstrated on ultrasound." | 9.09 | Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. ( Backos, M; Baxter, N; Chilcott, IT; Cohen, H; Rai, R; Regan, L, 1999) |
| "This preliminary study suggests that low-dose aspirin has no additional benefit when added to supportive care for women for whom recurrent early fetal loss is the only sequela of the antiphospholipid syndrome." | 9.09 | Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. ( Birdsall, M; Chamley, LW; Liddell, HS; McDougall, J; Pattison, NS; Zanderigo, AM, 2000) |
| "To determine the effectiveness of low dose aspirin in women at high risk of adverse outcomes associated with pre-eclampsia." | 9.08 | ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group. ( , 1996) |
| "Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody-associated recurrent pregnancy loss." | 9.08 | Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. ( Kutteh, WH, 1996) |
| "Indications for aspirin during pregnancy are a matter of debate and there is a recent trend to an extended prescription and an overuse of aspirin in pregnancy." | 9.01 | [Aspirin and preeclampsia]. ( Atallah, A; Doret-Dion, M; Gaucherand, P; Goffinet, F; Lecarpentier, E; Tsatsaris, V, 2019) |
| "The use of low-dose aspirin and heparinoids has improved the pregnancy outcome in obstetric antiphospholipid syndrome (APS)." | 8.93 | The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. ( Branch, DW; Hunt, BJ; Khamashta, M; Levy, RA; Middeldorp, S; Pavord, S; Roccatello, D; Ruiz-Irastorza, G; Schreiber, K; Sciascia, S; Tincani, A, 2016) |
| "The combination of heparin and aspirin was regarded as the 'standard therapy' for patients with recurrent pregnancy loss (RPL) and positive aPL antibodies to enhance live births, but it largely stems from expert opinion." | 8.86 | Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. ( Cheak, AA; Cheung, MW; Ho, RC; Mak, A, 2010) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 8.86 | WITHDRAWN: Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, G, 2010) |
| "We assessed the effects and safety of aspirin treatment during pregnancy on fetal and neonatal outcomes." | 8.82 | Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. ( Boskovic, R; Costei, AM; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2003) |
| " In patients with arterial or venous thrombosis, there is a high rate of recurrence during the two first years except if high-dose warfarin was used (i." | 8.80 | [Aspirin and antiphospholipid syndrome]. ( Blétry, O; Hachulla, E; Hatron, PY; Piette, AM, 2000) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 8.80 | Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, GL, 2000) |
| "The objective of the study was to compare the efficacy of low-molecular weight heparin (LMWH) alone and use in the combination with aspirin in the treatment of fetal growth restriction (FGR) patients." | 8.12 | Comparison of Low Molecular Weight Heparin Used alone or Combined with Aspirin in the Treatment of Fetal Growth Restriction. ( He, S; Liang, L, 2022) |
| "Aspirin is widely used to prevent pregnancy related vascular disorders such as preeclampsia (PE), intrauterine growth restriction and maternal disorders." | 8.02 | Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis. ( Dorsamy, V; Khaliq, OP; Mkhize, PZ; Moodley, J; Phoswa, WN, 2021) |
| "To evaluate the effects of low-molecular-weight heparin (LMWH) combined with low-dose aspirin (LDA) in pregnant women with a history of pregnancy-related hypertensive disorders." | 8.02 | Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study. ( Chen, Y; Shen, F; Wang, J; Yang, W; Zhang, Y; Zhou, J, 2021) |
| "The current treatment to prevent pregnancy morbidity (PM) associated with antiphospholipid antibodies (aPL) is based on the use of low dose aspirin and low molecular weight heparin (henceforth defined as standard of care (SoC) treatment)." | 7.96 | Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. ( Cecchi, I; Cuadrado, MJ; Radin, M; Roccatello, D; Rubini, E; Schreiber, K; Sciascia, S, 2020) |
| "A previous pilot study showed that pravastatin supplementation improved pregnancy outcomes in women with obstetric antiphospholipid syndrome (OAPS) that developed placental insufficiency despite standard of care treatment low molecular weight heparin plus low dose aspirin (LMWH + LDA)." | 7.96 | Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism. ( Contento, G; Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E; Pombo, J; Varoudi, K, 2020) |
| "Women with lupus have an increased risk of preeclampsia and preterm birth, and aspirin 81 mg/day is recommended as a preventative measure for preeclampsia." | 7.91 | Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study. ( Clowse, MEB; Eudy, AM; Myers, RA; Voora, D, 2019) |
| "The beneficial effect of aspirin in the prevention of preterm preeclampsia may not apply in pregnancies with chronic hypertension." | 7.85 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. ( Akolekar, R; De Stefani, L; Delgado, JL; Evangelinakis, N; Gonzalez-Vanegas, O; Jani, JC; Leipold, G; Nicolaides, KH; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tsokaki, T; Wright, D, 2017) |
| "Ticagrelor was daily administered throughout pregnancy to a 37-year-old pregnant woman until 36 weeks of gestation." | 7.81 | Use of ticagrelor in human pregnancy, the first experience. ( Jacquemyn, Y; Mannaerts, D; Muys, J; Verbruggen, M, 2015) |
| "Verify that resistance to aspirin may have an impact on pregnancy and neonatal outcome." | 7.77 | Aspirin resistance may be associated with adverse pregnancy outcomes. ( Huras, H; Jach, R; Musiał, J; Reroń, A; Rytlewski, K; Undas, A; Wilczak, M; Wójtowicz, A, 2011) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 7.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| "To assess the prevalence of haemostatic abnormalities in patients with an obstetric history of preeclampsia and/or fetal growth restriction and documented thrombophilia, and to evaluate the effects of low-molecular-weight heparin (LMWH) and aspirin on pregnancy outcome." | 7.70 | Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. ( de Vries, JI; Dekker, GA; Huijgens, PC; Leeda, M; Riyazi, N; van Geijn, HP, 1998) |
| "Self-reported use or consumption of tobacco, marijuana, cocaine, aspirin, and other nonsteroidal antiinflammatory drugs during pregnancy." | 7.69 | Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. ( Allred, EN; Cohen, A; Epstein, MF; Leviton, A; Pagano, M; Sullivan, KF; Van Marter, LJ, 1996) |
| "To describe patterns of prescription in the Netherlands of low-dose aspirin in pregnancy." | 7.68 | Low-dose aspirin in pregnancy: changes in patterns of prescription in The Netherlands. ( Bremer, HA; Wallenburg, HC, 1993) |
| " Many studies have suggested that treatment with low-dose aspirin and steroids is effective in preventing pregnancy loss or pre-eclampsia, but the mechanism has not been established." | 7.68 | [A trial of low-dose aspirin therapy in high-risk pregnancy]. ( Mochizuki, M; Morikawa, H; Ohashi, M; Takashima, M; Yamasaki, M, 1992) |
| "A 27-year-old woman with anti-phospholipid antibody syndrome, whose first pregnancy had ended in intrauterine fetal death, was treated with prednisolone 0." | 7.68 | [Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome]. ( Maruyama, I; Maruyama, Y; Okadome, T; Osame, M; Shimmyozu, K; Tara, M, 1990) |
| "The incidence of preterm preeclampsia was 1." | 7.30 | Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial. ( Alsius, M; Bonacina, E; Caamiña, S; Carreras, E; de Mingo, L; Diaz, S; Ferrer-Costa, R; Garcia, E; Garcia-Manau, P; López, M; Lopez-Quesada, E; Maiz, N; Maroto, A; Martin, L; Mendoza, M; Millán, P; Ocaña, V; Orizales-Lago, C; Pallarols, M; Pérez-Gomez, A; Pintado, E; Puerto, L; Ricart, M; Rodríguez-Zurita, A; Suy, A; Teixidor, M; Vidal-Sagnier, L; Vives, À, 2023) |
| " These inconsistencies, however, can be largely explained by a high degree of heterogeneity regarding the selection of trial participants, baseline risk of the included women, dosage of aspirin, gestational age of prophylaxis initiation, and preeclampsia definition." | 6.82 | Prevention of preeclampsia with aspirin. ( Nicolaides, KH; Poon, LC; Rolnik, DL, 2022) |
| "Outcomes included preeclampsia (mild and severe) and SGA neonates." | 6.53 | Prevention of Preeclampsia with Aspirin in Multiple Gestations: A Systematic Review and Meta-analysis. ( Bergeron, TS; Bujold, E; Carpentier, C; McCaw-Binns, A; Roberge, S; Sibai, B, 2016) |
| "Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 5.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
| "Acute fatty liver is a rare but fatal complication of pregnancy." | 5.32 | Acute fatty liver of pregnancy after aspirin intake. ( Deren, O; Durukan, T; Kizilkiliç-Parlakgümüş, A; Onderoğlu, L; Saygan-Karamürsel, B, 2004) |
| "The EAGeR trial randomly assigned 1228 women with a history of pregnancy loss to receive 81 mg aspirin or placebo for up to six menstrual cycles of attempting pregnancy and, if they became pregnant, throughout pregnancy." | 5.30 | Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes. ( Hill, M; Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2019) |
| "After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 5.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
| " Comparing women with stage 1 hypertension and normotensive women receiving low-dose aspirin during pregnancy (n=1,465), no differences in rates of preeclampsia (7." | 5.27 | Maternal Outcomes Associated With Lower Range Stage 1 Hypertension. ( Caritis, SN; Catov, JM; Hauspurg, A; Powers, RW; Sutton, EF, 2018) |
| " It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia." | 5.24 | Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. ( Akolekar, R; Cicero, S; de Paco Matallana, C; Gizurarson, S; Janga, D; Jani, JC; Maclagan, K; Meiri, H; Molina, FS; Nicolaides, KH; O'Gorman, N; Papaioannou, G; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Singh, M; Syngelaki, A; Tenenbaum-Gavish, K; Wright, D, 2017) |
| "The objective of the study is to evaluate low-dose aspirin (LDA) for pre-eclampsia prevention in twin gestations with elevated maternal serum human chorionic gonadotropin (hCG)." | 5.22 | Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin. ( Allshouse, AA; Euser, AG; Heyborne, KD; Metz, TD, 2016) |
| "A randomized clinical trial, Effects of Aspirin in Gestation and Reproduction, enrolled women with 1 or 2 prior pregnancy losses at 4 US clinical centers from June 15, 2007, to July 15, 2011." | 5.22 | Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial. ( Galai, N; Grantz, KL; Hinkle, SN; Mitchell, EM; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA, 2016) |
| "Aspirin supplementation was associated with worse outcomes related to preterm birth in smokers in a high-risk but not low-risk cohort." | 5.20 | Low-dose aspirin, smoking status, and the risk of spontaneous preterm birth. ( Abramovici, A; Biggio, J; Cantu, J; Edwards, R; Jauk, V; Tita, A; Wetta, L, 2015) |
| "To evaluate the effect of low-dose aspirin in prevention of adverse pregnancy outcomes (APO) in women with second trimester alpha-fetoprotein (AFP) >2." | 5.19 | Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein. ( Alavi, A; Borna, S; Hantoushzadeh, S; Khazardoost, S; Khezerlou, N; Mousavi, S, 2014) |
| "The objectives of this study are to examine the efficacy and safety of low-dose aspirin (LDA) vs LDA plus low-intensity warfarin (LDA + W) in the primary thrombosis prevention of aPL-positive patients with SLE and/or obstetric morbidity and the role of clinical and serological markers in the development of thrombosis." | 5.19 | Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). ( Aguirre, A; Akil, M; Amigo, MC; Bertolaccini, ML; Cuadrado, MJ; Egurbide, MV; Espinosa, G; Galindo, M; Gil, A; Gordon, C; Houssiau, F; Khamashta, MA; Martin, H; McHugh, N; Mico, L; Murru, V; Rahman, A; Ruiz-Irastorza, G; Seed, PT; Tektonidou, MG, 2014) |
| "Preconception-initiated low-dose aspirin might positively affect pregnancy outcomes, but this possibility has not been adequately assessed." | 5.19 | Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. ( Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Silver, RM; Townsend, JM; Wactawski-Wende, J, 2014) |
| "To determine whether low molecular weight heparin (LMWH) plus low-dose aspirin (LDA) is comparable in efficacy and safety to unfractionated heparin (UFH) plus LDA in the management of pregnant women with a history of recurrent spontaneous abortion secondary to antiphospholipid syndrome (APS)." | 5.15 | Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. ( Abdou, AM; Fouda, IM; Fouda, UM; Ramadan, DI; Sayed, AM; Zaki, MM, 2011) |
| "The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty." | 5.12 | The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies. ( Calligaro, A; Del Ross, T; Favaro, M; Gervasi, MT; Hoxha, A; Ruffatti, A; Ruffatti, AT; Tonello, M, 2021) |
| "This was a prospective clinical trial conducted at Khartoum Fertility Center, during the period June 2002 to February 2005 to investigate the efficacy of unfractionated heparin and low-dose aspirin as prophylaxis against pregnancy loss in 58 pregnant Sudanese women with recurrent (> or = 3) miscarriages associated with antiphospholipid syndrome (APS)." | 5.12 | Heparin and aspirin in pregnant Sudanese women with recurrent miscarriage associated with antiphospholipid antibodies. ( A/Magid, YM; A/Rahim, F; Adam, I; Elussein, EA; Omer, MM; Samaan, SI, 2007) |
| "Aspirin desensitization may be a safe alternative even during pregnancy if carefully monitored and permit patients with APS to receive treatment with ASA." | 5.12 | Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients. ( Alijotas-Reig, J; Cisteró-Bahíma, A; San Miguel-Moncín, M, 2006) |
| "To compare the effect of aspirin and enoxaparin on live births in women with unexplained recurrent miscarriages, as well as secondary outcomes including birth weight, uterine and umbilical blood flows, and congenital malformations." | 5.12 | A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. ( Brenner, B; Carp, H; Dolitzky, M; Inbal, A; Segal, Y; Weiss, A, 2006) |
| "To compare low molecular weight heparin (LMWH), specifically dalteparin, to unfractionated heparin (UFH) for the treatment of antiphospholipid antibody syndrome (APS) in pregnancy." | 5.11 | Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. ( Ballem, PJ; Ensom, MH; Ensworth, S; Houlihan, E; Purkiss, S; Stephenson, MD; Tsang, P, 2004) |
| "To evaluate the use of low-molecular-weight heparin (LMWH) in combination with low-dose aspirin (LDA) for the treatment of antiphospholipid antibody (APA)-associated recurrent pregnancy loss and to compare the results with the use of unfractionated heparin (UFH) plus LDA." | 5.11 | Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. ( Franklin, RD; Herrada, J; Kutteh, WH; Lashey, N; Noble, LS, 2005) |
| "To compare the 2 most efficacious therapeutic regimens, intravenous immunoglobulin (IVIG) and anticoagulation with low molecular weight (LMW) heparin plus low-dose aspirin, in women with recurrent pregnancy loss associated with antiphospholipid antibodies (aPL)." | 5.10 | Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. ( Accardo-Palumbo, A; Castelli, A; Ciccia, F; Ferrante, A; Giarratano, A; Licata, G; Perino, A; Triolo, G, 2003) |
| " Aspirin (75 mg daily) was commenced at the time of a positive pregnancy test and heparin (5000 units subcutaneously 12 hourly, or enoxaparin 20 mg daily) was started when fetal heart activity was demonstrated on ultrasound." | 5.09 | Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. ( Backos, M; Baxter, N; Chilcott, IT; Cohen, H; Rai, R; Regan, L, 1999) |
| "This preliminary study suggests that low-dose aspirin has no additional benefit when added to supportive care for women for whom recurrent early fetal loss is the only sequela of the antiphospholipid syndrome." | 5.09 | Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. ( Birdsall, M; Chamley, LW; Liddell, HS; McDougall, J; Pattison, NS; Zanderigo, AM, 2000) |
| "Aspirin therapy increased birth weight in all women, especially in women with high human chorionic gonadotropin levels, partly by increasing gestational age at delivery." | 5.08 | The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels. ( DuBard, MB; Goldenberg, RL; Hauth, JC; Lea, C; Wenstrom, KD, 1995) |
| "To determine the effectiveness of low dose aspirin in women at high risk of adverse outcomes associated with pre-eclampsia." | 5.08 | ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group. ( , 1996) |
| "Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody-associated recurrent pregnancy loss." | 5.08 | Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. ( Kutteh, WH, 1996) |
| "8 mg per kilogram of body weight per day) and aspirin (100 mg per day) or placebo for the duration of the pregnancy." | 5.08 | Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. ( Bombardier, C; Farewell, V; Farine, D; Fielding, L; Hannah, ME; Laskin, CA; Mandel, FP; Ritchie, JW; Soloninka, CA; Spitzer, K; Yeung, M, 1997) |
| "We compared the use of aspirin alone with combined therapy (prednisone plus aspirin) in antiphospholipid antibody-positive obstetric patients with prior adverse pregnancy outcome." | 5.07 | Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. ( Hobart, JM; MacGregor, SN; Neerhof, MG; Ragin, A; Sholl, JS; Silver, RK, 1993) |
| "Literature on the efficacy and safety of enoxaparin for thromboembolism and thromboprophylaxis remains scanty, and therefore efficacy was not assessed; in terms of safety, when including other indications for enoxaparin in pregnancy, we found that enoxaparin was associated with significantly lower complications than aspirin." | 5.05 | Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. ( Jacobson, B; Leisegang, R; Naidoo, P; Paek, D; Rambiritch, V; Sayre, T; Shan, J, 2020) |
| "Indications for aspirin during pregnancy are a matter of debate and there is a recent trend to an extended prescription and an overuse of aspirin in pregnancy." | 5.01 | [Aspirin and preeclampsia]. ( Atallah, A; Doret-Dion, M; Gaucherand, P; Goffinet, F; Lecarpentier, E; Tsatsaris, V, 2019) |
| "The use of aspirin and heparin has improved the pregnancy outcome in obstetric APS and approximately 70% of pregnant women with APS have a successful pregnancy outcome." | 4.95 | Current insights in obstetric antiphospholipid syndrome. ( Radin, M; Schreiber, K; Sciascia, S, 2017) |
| "The use of low-dose aspirin and heparinoids has improved the pregnancy outcome in obstetric antiphospholipid syndrome (APS)." | 4.93 | The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. ( Branch, DW; Hunt, BJ; Khamashta, M; Levy, RA; Middeldorp, S; Pavord, S; Roccatello, D; Ruiz-Irastorza, G; Schreiber, K; Sciascia, S; Tincani, A, 2016) |
| " Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions." | 4.93 | [Antiphospholipid syndrome and pregnancy]. ( Jacobsen, S; Langhoff-Roos, J; Lykke, JA; Nielsen, HS; Schreiber, K, 2016) |
| " Current treatment of patients with antiphospholipid syndrome (APS) during pregnancy with heparin and aspirin can act by preventing clot formation and improving live birth rates, but other obstetric morbidities remain high, especially in patients with a history of thrombotic events." | 4.90 | Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? ( de Jesús, GR; de Jesús, NR; Levy, RA; Rodrigues, G, 2014) |
| "The combination of heparin and aspirin was regarded as the 'standard therapy' for patients with recurrent pregnancy loss (RPL) and positive aPL antibodies to enhance live births, but it largely stems from expert opinion." | 4.86 | Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. ( Cheak, AA; Cheung, MW; Ho, RC; Mak, A, 2010) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 4.86 | WITHDRAWN: Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, G, 2010) |
| " Low dose aspirin should be given to every pregnant woman with antiphospholipid antibodies, with the addition of low molecular weight heparin in those with previous thrombosis, previous fetal death or failure of monotherapy with aspirin." | 4.85 | [The antiphospholipid syndrome in the 21st century]. ( Egurbide, MV; Martinez-Berriotxoa, A; Ruiz-Irastorza, G, 2009) |
| " Clinical trials have demonstrated that patients with antiphospholipid antibodies and venous thromboembolism should be treated with vitamin K antagonists (warfarin); that ischemic stroke may be treated with aspirin or warfarin; and that women with recurrent pregnancy loss should receive prophylactic-dose heparin and aspirin." | 4.85 | Antiphospholipid antibody syndrome. ( Lim, W, 2009) |
| "We assessed the effects and safety of aspirin treatment during pregnancy on fetal and neonatal outcomes." | 4.82 | Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. ( Boskovic, R; Costei, AM; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2003) |
| "NSAIDs or cyclooxygenase inhibitors (COX inhibitors), including aspirin, are widely used to treat pain, fever and the articular symptoms of chronic rheumatic diseases." | 4.82 | Anti-inflammatory pharmacotherapy during pregnancy. ( Skomsvoll, JF; Østensen, ME, 2004) |
| "Although intra-uterine fetal death is considered at high risk of recurrence in case of antiphospholipid syndrome (APS), a uniform management protocol including aspirin and heparin and close obstetrical follow-up led to a favorable outcome in most cases." | 4.82 | Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy. ( Bats, AS; Carbonne, B; Cynober, E; Gonzales, M; Lejeune, V; Milliez, J; Safar, E, 2004) |
| " The management of pregnant patients with antiphospholipid syndrome is mainly based on the use of antiaggregant/anticoagulant agents (with aspirin and heparin) to prevent thrombosis in the uteroplacental circulation." | 4.82 | The management of pregnant patients with antiphospholipid syndrome. ( Balasch, J; Cervera, R, 2004) |
| " In patients with arterial or venous thrombosis, there is a high rate of recurrence during the two first years except if high-dose warfarin was used (i." | 4.80 | [Aspirin and antiphospholipid syndrome]. ( Blétry, O; Hachulla, E; Hatron, PY; Piette, AM, 2000) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 4.80 | Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, GL, 2000) |
| " Hence, in several patient series the use of IVIg either solely or in combination with aspirin/heparin resulted in successful pregnancy outcome in the vast majority of APS patients with recurrent abortions." | 4.80 | Intravenous immunoglobulin therapy of antiphospholipid syndrome. ( Levy, Y; Sherer, Y; Shoenfeld, Y, 2000) |
| "Current trends of pharmacological research on inflammation are outlined, with particular reference to some agents differing from the aspirin-like and the corticosteroids in their mode and mechanism of action." | 4.77 | Current trends in the research on antiinflammatory agents. ( Bertelli, A; Silvestrini, B, 1985) |
| "l-Arginine, aspirin and vitamin D are promising, high-potential preventative agents for fetal growth restriction." | 4.31 | Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction. ( Ammerdorffer, A; Goldstein, M; Gülmezoglu, AM; Hastie, R; Lim, S; McDougall, ARA; Ricci, C; Rushwan, S; Tong, S; Tuttle, A; Vogel, JP, 2023) |
| " Our example is an analysis assessing the impact of taking aspirin on pregnancy, 26 weeks after randomization, in the Effects of Aspirin in Gestation and Reproduction trial (United States, 2006-2012)." | 4.12 | The Role of the Natural Course in Causal Analysis. ( Bodnar, LM; Cartus, A; Naimi, AI; Rudolph, JE; Schisterman, EF, 2022) |
| "The objective of the study was to compare the efficacy of low-molecular weight heparin (LMWH) alone and use in the combination with aspirin in the treatment of fetal growth restriction (FGR) patients." | 4.12 | Comparison of Low Molecular Weight Heparin Used alone or Combined with Aspirin in the Treatment of Fetal Growth Restriction. ( He, S; Liang, L, 2022) |
| "Aspirin is widely used to prevent pregnancy related vascular disorders such as preeclampsia (PE), intrauterine growth restriction and maternal disorders." | 4.02 | Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis. ( Dorsamy, V; Khaliq, OP; Mkhize, PZ; Moodley, J; Phoswa, WN, 2021) |
| "To evaluate the effects of low-molecular-weight heparin (LMWH) combined with low-dose aspirin (LDA) in pregnant women with a history of pregnancy-related hypertensive disorders." | 4.02 | Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study. ( Chen, Y; Shen, F; Wang, J; Yang, W; Zhang, Y; Zhou, J, 2021) |
| "5%) with a history of pregnancy morbidity alone were treated with prophylactic low molecular weight heparin (LMWH) + low-dose aspirin (LDA, 100 mg) (group I) and 40 (31." | 3.96 | Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study. ( Calligaro, A; Del Ross, T; Favaro, M; Hoxha, A; Infantolino, C; Mattia, E; Ruffatti, A; Ruffatti, AT; Tonello, M, 2020) |
| "The current treatment to prevent pregnancy morbidity (PM) associated with antiphospholipid antibodies (aPL) is based on the use of low dose aspirin and low molecular weight heparin (henceforth defined as standard of care (SoC) treatment)." | 3.96 | Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. ( Cecchi, I; Cuadrado, MJ; Radin, M; Roccatello, D; Rubini, E; Schreiber, K; Sciascia, S, 2020) |
| "A previous pilot study showed that pravastatin supplementation improved pregnancy outcomes in women with obstetric antiphospholipid syndrome (OAPS) that developed placental insufficiency despite standard of care treatment low molecular weight heparin plus low dose aspirin (LMWH + LDA)." | 3.96 | Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism. ( Contento, G; Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E; Pombo, J; Varoudi, K, 2020) |
| "Women with lupus have an increased risk of preeclampsia and preterm birth, and aspirin 81 mg/day is recommended as a preventative measure for preeclampsia." | 3.91 | Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study. ( Clowse, MEB; Eudy, AM; Myers, RA; Voora, D, 2019) |
| "Women with antiphospholipid antibodies (aPL) are at risk for pregnancy complications despite treatment with low molecular weight heparin (LMWH) or aspirin (ASA)." | 3.88 | Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies. ( Abrahams, VM; Bryce, E; Chamley, LW; Guller, S; Quao, ZC; Tong, M, 2018) |
| "The beneficial effect of aspirin in the prevention of preterm preeclampsia may not apply in pregnancies with chronic hypertension." | 3.85 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. ( Akolekar, R; De Stefani, L; Delgado, JL; Evangelinakis, N; Gonzalez-Vanegas, O; Jani, JC; Leipold, G; Nicolaides, KH; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tsokaki, T; Wright, D, 2017) |
| "The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody syndrome (APS) includes prolonged treatment with heparin and aspirin, starting from the confirmation of pregnancy and continuing until 6 weeks after birth." | 3.85 | Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study. ( Chi, HB; Liu, P; Qiao, J; Song, Y; Wang, HY, 2017) |
| "In the final regression model, VFD was associated with maternal consumption of aspirin during the current pregnancy, recurring/persistent acidemia during the first 3 postnatal days, cerebral ventriculomegaly seen on neonatal ultrasound, prethreshold retinopathy of prematurity (ROP), and supplemental oxygen and ventilator dependence at 36 weeks post-menstrual age." | 3.81 | Antecedents and correlates of visual field deficits in children born extremely preterm. ( Allred, E; Dammann, O; Holm, M; Leviton, A; Msall, ME; Skranes, J, 2015) |
| " This study aims to investigate whether calcium channel blockers plus low dosage aspirin therapy can reduce the incidence of complications during pregnancy with chronic hypertension and improve the prognosis of neonates." | 3.81 | The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension. ( Jiang, N; Liu, L; Liu, Q; Yang, WW; Zeng, Y, 2015) |
| "Ticagrelor was daily administered throughout pregnancy to a 37-year-old pregnant woman until 36 weeks of gestation." | 3.81 | Use of ticagrelor in human pregnancy, the first experience. ( Jacquemyn, Y; Mannaerts, D; Muys, J; Verbruggen, M, 2015) |
| "The effect of low-dose aspirin (LDA) on pregnancy outcome in antiphospholipid (aPL)-positive women not fulfilling the criteria for antiphospholipid antibody syndrome (APS) was evaluated retrospectively." | 3.79 | Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study. ( Calligaro, A; Del Ross, T; Favaro, M; Hoxha, A; Punzi, L; Ruffatti, A; Tonello, M; Visentin, MS, 2013) |
| "Women with persistent aPL on aspirin had pregnancy outcomes that were similar to controls." | 3.79 | Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes. ( Gray, G; Nelson-Piercy, C; Pasupathy, D; Soh, MC, 2013) |
| "To identify patients at very high risk for adverse pregnancy outcome (APO) at the 20- to 23-week scan and to assess the effectiveness of Aspirin (ASS) and low molecular weight heparin (LMWH) starting after this examination." | 3.79 | Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects. ( Becker, R; Bittner, U; Fangerau, H; Keller, T; Kiesewetter, H, 2013) |
| " In normal female rats, the sera total thyroxine (TT4) and total triiodothyronine (TT3) levels were detectably increased at day 10 post-partum than those at day 10 of pregnancy." | 3.78 | Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-the developmental pattern of neurons in relation to oxidative stress and antioxidant defense system. ( Abd El-Tawab, SM; Ahmed, OM; Ahmed, RG; El-Bakry, AM; El-Gareib, AW, 2012) |
| " After delivery, aspirin was prescribed to all patients as primary thrombosis prevention." | 3.77 | Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients. ( Bacri, JL; Caron, C; Dubucquoi, S; Hachulla, E; Hatron, PY; Houfflin-Debarge, V; Kyndt, X; Lambert, M; Launay, D; Lefèvre, G; Quemeneur, T; Subtil, D, 2011) |
| "Verify that resistance to aspirin may have an impact on pregnancy and neonatal outcome." | 3.77 | Aspirin resistance may be associated with adverse pregnancy outcomes. ( Huras, H; Jach, R; Musiał, J; Reroń, A; Rytlewski, K; Undas, A; Wilczak, M; Wójtowicz, A, 2011) |
| "Low molecular weight (LMW) heparin, with or without aspirin (acetylsalicylic acid [ASA]), is used to prevent complications in antiphospholipid syndrome in pregnancy." | 3.77 | Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. ( Abrahams, VM; Brosens, JJ; Chamley, LW; Han, CS; Lockwood, CJ; Mulla, MJ; Paidas, MJ, 2011) |
| "The USPSTF recommends aspirin for the prevention of stroke and heart attack for those at risk, and screening for major depression and childhood obesity." | 3.76 | USPSTF recommendations you may have missed amid the breast cancer controversy. ( Campos-Outcalt, D, 2010) |
| " When treatment was analyzed, 53/67 (79%) of women with APLAs who had received aspirin and heparin during their pregnancy had a live birth, compared with 64/104 (62%) of women with APLAs who received aspirin only (adjusted OR 2." | 3.76 | Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. ( Cohn, DM; Dawood, F; Farquharson, RG; Goddijn, M; Korevaar, JC; Middeldorp, S, 2010) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 3.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| " With a treatment that included aspirin, heparin, and a nitric oxide donor, her third pregnancy ended with a healthy neonate at term." | 3.74 | Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma. ( Cabane, J; Carbonne, B; Cynober, E; Macé, G; Milliez, J, 2007) |
| "Management recommendations displayed reasonable consistence: (i) for the use of low-dose aspirin and low-molecular weight heparin during pregnancy and during ovarian stimulation for in vitro fertilization; (ii) against oestrogen-containing oral contraceptives; and (iii) for the use of anticoagulants in the post-partum period." | 3.74 | Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. ( Erkan, D; Gerosa, M; Lockshin, MD; Meroni, PL; Nuzzo, M; Patel, S; Tincani, A, 2008) |
| "Our results reaffirm previous reports that the use of LMWH in combination with low dose aspirin throughout pregnancy is safe and effective." | 3.73 | Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology. ( Delkos, D; Giannoulis, H; Gkoutzioulis, F; Kalogiros, G; Papaloukas, C; Petropoulos, P; Psarra, A; Tzafettas, J, 2005) |
| "We report the cases of two patients who had a favorable outcome with aspirin and corticosteroid therapy during pregnancy for chronic villitis of unknown etiology complicated by labor asphyxia and further intrauterine fetal demise in one gravida 3 patient and for chronic intervillositis of unknown etiology diagnosed after three perinatal deaths in another patient (gravida 4)." | 3.73 | [Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology]. ( Alnoukari, F; Barrier, J; Boog, G; Jossic, F; Le Vaillant, C; Muller, JY, 2006) |
| " Out of the 9 pregnancies with high dose low-molecular-weight heparin and low dose aspirin thromboprophylaxis throughout pregnancy 8 were successful (88." | 3.72 | [Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome]. ( Boda, Z; Kerényi, A; Lakos, G; László, P; Pfliegler, G; Pósán, E; Rázsó, K; Schlammadinger, A, 2003) |
| "The prevention of preeclampsia currently relies on low-dose aspirin started at the beginning of pregnancy." | 3.72 | [Prevention of preeclampsia]. ( Desvaux, D; Haddad, B, 2003) |
| "To evaluate the pregnancy outcome in patients with abnormal uterine artery Doppler flow velocity waveforms (FVW's) at 19-21 weeks, which were subsequently normal by 24-26 weeks, and to study the effect of low-dose aspirin on these waveforms." | 3.72 | Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon. ( Fayyad, A; Harrington, K; Kurdi, W; Thakur, V, 2004) |
| "We recently reported links between frequent paracetamol (acetaminophen) use and wheezing and asthma in adults and children, but data are lacking on possible effects of prenatal exposure on wheezing in early childhood." | 3.71 | Paracetamol use in pregnancy and wheezing in early childhood. ( Burney, PG; Golding, J; Henderson, AJ; Heron, JE; Newson, RB; Shaheen, SO; Sherriff, A, 2002) |
| "The present report shows that in treated APS pregnancies: i) aspirin treatment started preconceptionally is an independent and significant prognostic factor associated with favorable fetal outcome; and ii) abnormal velocity waveforms in the umbilical artery predict adverse outcome of pregnancy." | 3.71 | Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. ( Azulay, M; Balasch, J; Carmona, F; Cervera, R; Creus, M; Fábregues, F; Font, J; Puerto, B, 2001) |
| " A successful pregnancy outcome was achieved by combined therapy with aspirin, low-molecular-weight heparin, prednisone, and enzyme replacement therapy with imiglucerase." | 3.71 | Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome. ( Dulitzki, M; Langevitz, P; Levy, Y; Livneh, A; Sherer, Y; Shoenfeld, Y, 2002) |
| "Authors describe a successful pregnancy outcome after prednisone and aspirin therapy in 19-year-old woman with systemic lupus erythematosus with the history of recurrent urinary tract infections, pericarditis and encephalitis." | 3.71 | [Course of pregnancy in a patient with systemic lupus erythematosus--case report]. ( Goluda, M; Jerzak, MM; Podwysocka, M; Prusek, W, 2002) |
| "To assess the prevalence of haemostatic abnormalities in patients with an obstetric history of preeclampsia and/or fetal growth restriction and documented thrombophilia, and to evaluate the effects of low-molecular-weight heparin (LMWH) and aspirin on pregnancy outcome." | 3.70 | Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. ( de Vries, JI; Dekker, GA; Huijgens, PC; Leeda, M; Riyazi, N; van Geijn, HP, 1998) |
| "Heparin plus aspirin significantly improves the live birth rate of women with primary antiphospholipid syndrome." | 3.70 | Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study. ( Backos, M; Doré, C; Murphy, M; Rai, R; Regan, L; Thomas, E, 1999) |
| "This prospective study is an attempt to address the issues of whether or not antiphospholipid antibodies (aPL) constitute a significant risk factor for pregnancy in individuals with systemic lupus erythematosus (SLE) and whether or not combination therapy of high-dose prednisolone (PSL) and low-dose acetylsalicylic acid (ASA) offers efficient control." | 3.69 | A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus. ( Aoki, K; Hayashi, Y; Ogasawara, M, 1995) |
| "Self-reported use or consumption of tobacco, marijuana, cocaine, aspirin, and other nonsteroidal antiinflammatory drugs during pregnancy." | 3.69 | Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. ( Allred, EN; Cohen, A; Epstein, MF; Leviton, A; Pagano, M; Sullivan, KF; Van Marter, LJ, 1996) |
| "The aim of this study was to determine the neonatal outcome in women with well-characterized antiphospholipid syndrome treated during pregnancy with low-dose aspirin." | 3.69 | Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. ( Balasch, J; Botet, F; Carmona, F; Figueras, J; Montagut, P; Romera, G, 1997) |
| " In 1982, it was suggested for the first time low doses of aspirin and prednisone for treatment of recurrent fetal death associated to this syndrome, heparin therapy was reported in 1984, recommended a doses of 15,000 U/day during first pregnancy trimester and 20,000 U/day posteriorly." | 3.69 | [Recurrent fetal death and antiphospholipid antibody syndrome. A case report]. ( Bustos López, HH; Hernández Andrade, E; Ramírez Peredo, J; Rojas-Poceros, G, 1997) |
| "To describe patterns of prescription in the Netherlands of low-dose aspirin in pregnancy." | 3.68 | Low-dose aspirin in pregnancy: changes in patterns of prescription in The Netherlands. ( Bremer, HA; Wallenburg, HC, 1993) |
| "A patient with systemic lupus erythematosus and elevated cardiolipin antibody levels was given low-dose aspirin therapy prior to and throughout her third pregnancy to minimize the risk of miscarriage." | 3.68 | Anticardiolipin syndrome, aspirin therapy and fetal malformation. ( Chakravarty, K; Merry, P, 1993) |
| "We examined the relation between the spontaneous remission and prednisolone-induced suppression of lupus anticoagulant (LAC) or anticardiolipin antibody (ACA) and pregnancy outcome in 5 LAC-positive women." | 3.68 | Lupus anticoagulant (LAC) and its relation to pregnancy outcome: a report of five cases. ( Hasegawa, M; Ihara, Y; Inamori, K; Itoh, H; Mandai, M; Mori, T; Niwa, H; Okagaki, A; Sagawa, N, 1993) |
| " Further investigation revealed that her mother had taken aspirin throughout pregnancy." | 3.68 | Toxic reaction to salicylate in a newborn infant: similarities to neonatal sepsis. ( Bond, GR; Buck, ML; Grebe, TA, 1993) |
| "We reviewed 82 consecutive pregnancies in 54 women with antiphospholipid syndrome who were treated during pregnancy with the following: 1) prednisone and low-dose aspirin; 2) heparin and low-dose aspirin; 3) prednisone, heparin, and low-dose aspirin; or 4) other combinations of these medications or immunoglobulin." | 3.68 | Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. ( Blackwell, JL; Branch, DW; Reading, JC; Scott, JR; Silver, RM, 1992) |
| " She had been treated with prophylactic, subcutaneous heparin and aspirin throughout her pregnancy." | 3.68 | Lupus anticoagulant, paramyotonia congenita and pregnancy. ( Douglas, MJ; Howell, PR, 1992) |
| " Many studies have suggested that treatment with low-dose aspirin and steroids is effective in preventing pregnancy loss or pre-eclampsia, but the mechanism has not been established." | 3.68 | [A trial of low-dose aspirin therapy in high-risk pregnancy]. ( Mochizuki, M; Morikawa, H; Ohashi, M; Takashima, M; Yamasaki, M, 1992) |
| " Immunoadsorbent plasmapheresis with a dextran sulphate column was used to remove lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA during her fourth pregnancy in combination with low doses of aspirin and prednisolone." | 3.68 | Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. ( Hashimoto, H; Hirose, S; Kobayashi, S; Mokuno, C; Tamura, N; Tsuda, H, 1992) |
| "A 27-year-old woman with anti-phospholipid antibody syndrome, whose first pregnancy had ended in intrauterine fetal death, was treated with prednisolone 0." | 3.68 | [Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome]. ( Maruyama, I; Maruyama, Y; Okadome, T; Osame, M; Shimmyozu, K; Tara, M, 1990) |
| " No correlations were found between premenstrual exacerbation of asthma and symptoms of premenstrual tension, consumption of aspirin, use of the contraceptive pill, cycle length, or behaviour of asthma during pregnancy." | 3.67 | Premenstrual exacerbation of asthma. ( Coutts, II; Finnegan, OC; Gibbs, CJ; Lock, R; White, RJ, 1984) |
| " During their next pregnancy, the patients were treated with 40 to 50 mg of prednisone per day and 81 mg of aspirin per day." | 3.67 | Obstetric complications associated with the lupus anticoagulant. ( Branch, DW; Hershgold, E; Kochenour, NK; Scott, JR, 1985) |
| "The incidence of preterm preeclampsia was 1." | 3.30 | Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial. ( Alsius, M; Bonacina, E; Caamiña, S; Carreras, E; de Mingo, L; Diaz, S; Ferrer-Costa, R; Garcia, E; Garcia-Manau, P; López, M; Lopez-Quesada, E; Maiz, N; Maroto, A; Martin, L; Mendoza, M; Millán, P; Ocaña, V; Orizales-Lago, C; Pallarols, M; Pérez-Gomez, A; Pintado, E; Puerto, L; Ricart, M; Rodríguez-Zurita, A; Suy, A; Teixidor, M; Vidal-Sagnier, L; Vives, À, 2023) |
| " These inconsistencies, however, can be largely explained by a high degree of heterogeneity regarding the selection of trial participants, baseline risk of the included women, dosage of aspirin, gestational age of prophylaxis initiation, and preeclampsia definition." | 2.82 | Prevention of preeclampsia with aspirin. ( Nicolaides, KH; Poon, LC; Rolnik, DL, 2022) |
| "When superimposed preeclampsia was present, it developed at an earlier gestational age among the group without GDM (35 ± 5 vs." | 2.82 | Rate of Gestational Diabetes Mellitus and Pregnancy Outcomes in Patients with Chronic Hypertension. ( Blackwell, SC; Haidar, ZA; Leon, MG; Longo, M; Mendez-Figueroa, H; Moussa, HN; Pedroza, C; Sibai, BM, 2016) |
| "Treatment with aspirin and heparin leads to a significantly higher rate of live births in women with a history of recurrent miscarriage associated with phospholipid antibodies than that achieved with aspirin alone." | 2.68 | Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) ( Cohen, H; Dave, M; Rai, R; Regan, L, 1997) |
| "We studied 14 pregnant women with systemic lupus erythematosus (SLE), of whom six had detectable antiphospholipid antibodies." | 2.67 | Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin. ( Julkunen, H; Kaaja, R; Viinikka, L; Ylikorkala, O, 1993) |
| "Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss." | 2.66 | Understanding and Preventing Placenta-Mediated Pregnancy Complications. ( Blondon, M; Ní Áinle, F; Skeith, L, 2020) |
| "Myeloproliferative neoplasms (MPNs) are increasingly being identified in women of childbearing potential." | 2.61 | Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis. ( Fazelzad, R; Gupta, V; Kazi, S; Malinowski, AK; Maze, D; Shah, PS; Shehata, N, 2019) |
| "Angiogenic and non-angiogenic preeclampsia are identified by a sFlt-1PlGF≥85 and<85, respectively, with the risk of maternal and fetal complications at two weeks differing between the two." | 2.61 | [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians]. ( Achiche, J; Ahriz Saksi, S; Bailleul, S; Boulanger, H; Drouin, D; Dupuis, E; Ekoukou, D; Lefèvre, G; Sault, C; Stawiarski, N, 2019) |
| " Avoidance of nephrotoxic and teratogenic medications is necessary, and renal dosing of commonly used medications must also be considered." | 2.61 | Chronic Kidney Disease and Pregnancy. ( Hladunewich, MA; Hui, D, 2019) |
| "Aspirin has proved its efficacy in primary and secondary pre-eclampsia prevention, especially when it is given at 150mg per day bedtime before 15 weeks of gestation to high-risk women." | 2.58 | [Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?] ( de Moreuil, C; Fauchais, AL; Lacut, K; Le Moigne, E; Merviel, P; Pan-Petesch, B; Pasquier, E; Tremouilhac, C, 2018) |
| "The pregnancy was uneventful." | 2.55 | Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review. ( Bohîlţea, RE; Cîrstoiu, MM; Dimitriu, M; Ionescu, CA; Niculescu-Mizil, E; Turcan, N; Vlădăreanu, AM; Voican, I, 2017) |
| "Outcomes included preeclampsia (mild and severe) and SGA neonates." | 2.53 | Prevention of Preeclampsia with Aspirin in Multiple Gestations: A Systematic Review and Meta-analysis. ( Bergeron, TS; Bujold, E; Carpentier, C; McCaw-Binns, A; Roberge, S; Sibai, B, 2016) |
| "Today, pregnancy is no longer considered impossible in women with lupus." | 2.53 | Pregnancy in women with systemic lupus erythematosus (SLE). ( Moroni, G; Ponticelli, C, 2016) |
| "For a woman with chronic pain, adequate use of pain killers during pregnancy is needed." | 2.53 | Ongoing Pharmacological Management of Chronic Pain in Pregnancy. ( Källén, B; Reis, M, 2016) |
| " Careful attention must be paid to the dosing and potential teratogenicity of medications." | 2.52 | Pregnancy and Lupus Nephritis. ( Garovic, VD; Kattah, AG, 2015) |
| "Obstetric antiphospholipid antibody syndrome (APS) is diagnosed in the presence of certain clinical features in conjunction with positive laboratory findings." | 2.50 | Antiphospholipid antibody syndrome. ( Hinote, CD; Kutteh, WH, 2014) |
| "Over-the-counter antipyretics (acetaminophen, aspirin, ibuprofen) and/or analgesics (acetaminophen, aspirin, diclofenac, ibuprofen, naproxen) are relatively safe for adults." | 2.48 | [Developmental toxicity of the over-the-counter analgetics and antypiretics]. ( Burdan, F; Cendrowska-Pinkosz, M; Dworzańska, A; Dworzański, W; Kubiatowski, T; Starosławska, E; Szumiło, J; Urbańczyk-Zawadzka, M, 2012) |
| "Adequate pregnancy care of women with systemic lupus erythematosus (SLE) rests on three pillars: a coordinated medical-obstetrical care, an agreed and well-defined management protocol and a good neonatal unit." | 2.47 | Lupus and pregnancy: integrating clues from the bench and bedside. ( Khamashta, MA; Ruiz-Irastorza, G, 2011) |
| "Obstetric antiphospholipid antibody syndrome (APS) is diagnosed in the presence of certain clinical features in conjunction with positive laboratory findings." | 2.47 | Obstetric antiphospholipid syndrome: an update on pathophysiology and management. ( Ernest, JM; Kutteh, WH; Marshburn, PB, 2011) |
| "Antiphospholipid syndrome is one of the few treatable causes of pregnancy loss, and successful pregnancy rates of 70% or more can be achieved with appropriate treatment." | 2.44 | [Pregnancy and antiphospholipid antibodies]. ( Goffinet, F; Le Guern, V, 2008) |
| "Aspirin has potential risks." | 2.44 | Aspirin and reproductive outcomes. ( Brancazio, LR; James, AH; Price, T, 2008) |
| "The antiphospholipid syndrome is currently best treated with anticoagulation." | 2.43 | Anticoagulation therapy in the antiphospholipid syndrome: recent advances. ( Crowther, MA; Ng, HJ, 2005) |
| "Aspirin, which was regarded as the drug of choice for the prevention of such obstetric complications, has proved to be ineffective in a large clinical trial." | 2.42 | Inherited thrombophilia and gestational vascular complications. ( Eldor, A; Kupferminc, MJ, 2003) |
| "The risk of preeclampsia and placental insufficiency was substantial and occurred in 50% of patients." | 2.42 | Antiphospholipid syndrome in obstetrics. ( Heilmann, L; Pollow, K; von Tempelhoff, GF, 2003) |
| "Many authors relate this factor with preeclampsia, intrauterine fetal growth retardation, spontaneous abortion, unexplained cases of still birth, placental abruption, and thromboembolic complications during and after parturition." | 2.42 | [Factor V Leiden mutation and pregnancy complications]. ( Abraitis, V; Mockeviciene, A; Mongirdiene, A, 2003) |
| "Migraine is a typical "women's disease": the fluctuations of sex hormones, in particular estrogens, during woman's reproductive life show a direct and major influence on migraine course." | 2.42 | [Migraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategies]. ( Airola, G; Allais, G; Benedetto, C; Bosio, A; Ciochetto, D; De Lorenzo, C; Mana, O; Quirico, PE; Terzi, MG, 2003) |
| "If diagnosed and treated early in pregnancy with low-dose aspirin and subcutaneous heparin the outlook for a successful pregnancy is much improved." | 2.41 | A literature review on the antiphospholipid syndrome and the effect on childbearing. ( Vials, JM, 2001) |
| "The occurrence of migraine in women is influenced by hormonal changes throughout the lifecycle." | 2.40 | Migraine in pregnancy: what are the safest treatment options? ( Pfaffenrath, V; Rehm, M, 1998) |
| "The use of drugs for common pregnancy complications like premature labor, hypertensive diseases, and premature rupture of membranes with chorioamnionitis is reviewed." | 2.39 | Drug treatment in pregnancy. ( Schneider, H, 1994) |
| "Insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE) are two common autoimmune disorders that affect women of childbearing age." | 2.39 | Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes. ( Ferris, AM; Reece, EA, 1994) |
| " Clinicians who decide to manage complicated or potentially complicated patients with chronic administration of aspirin must continue to study these mothers, fetuses, and neonates intensively and to document their results." | 2.38 | Low-dose aspirin to improve perinatal outcome. ( Barton, JR; Sibai, BM, 1991) |
| " The teratogenic potential of a drug is related to dosage and time of administration." | 2.36 | Analgesics during pregnancy. ( Niederhoff, H; Zahradnik, HP, 1983) |
| "Common complications of systemic lupus erythematosus include nephritis, hematologic complications such as thrombocytopenia, and a variety of neurologic abnormalities." | 1.91 | Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. ( Craigo, S; Kuller, JA; Norton, ME; Osmundson, SS; Porter, F; Silver, R, 2023) |
| " In age-adjusted analyses, aspirin plus LMWH regardless of dosage was associated with significantly higher odds of live birth compared with no antithrombotic use (OR = 7." | 1.91 | Management and outcomes of women with antiphospholipid syndrome during pregnancy. ( Adurty, S; D'Angelo, D; DeSancho, MT; Tao, JJ, 2023) |
| "Human pregnancy is associated with a mild proinflammatory state characterized by circulatory neutrophil activation which is further increased in complicated pregnancies, placenta-mediated complications being associated with an increased thrombotic risk." | 1.62 | NETosis Markers in Pregnancy: Effects Differ According to Histone Subtypes. ( Bouvier, S; Demattei, C; Fortier, M; Gris, JC; Herzog, M; Letouzey, V; Mercier, E; Mousty, E; Nouvellon, E; Rommelaere, G; Vincent, L, 2021) |
| "In this series, recurrent miscarriage is the most frequent poor outcome." | 1.51 | The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. ( Alijotas-Reig, J; Arnau, A; Belizna, C; Canti, V; Cervera, R; Chighizola, CB; De Carolis, S; Espinosa, G; Esteve-Valverde, E; Farran-Codina, I; Ferrer-Oliveras, R; Gerosa, M; Gogou, V; Hoxha, A; Latino, O; Lefkou, E; LLurba, E; Lundelin, K; Marozio, L; Martí-Cañamares, A; Mayer-Pickel, K; Mekinian, A; Pengo, V; Reshetnyak, T; Ríos-Garcés, R; Rovere-Querini, P; Ruffatti, A; Ruiz-Hidalgo, D; Sáez-Comet, L; Sos, L; Stojanovich, L; Stoppani, C; Tabacco, S; Tincani, A; Trapé, J; Varoudis, A, 2019) |
| "control)." | 1.48 | Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis. ( Akinshina, S; Bitsadze, V; Khamani, N; Khizroeva, J; Makatsariya, A, 2018) |
| "Recurrent spontaneous abortion is one of the common complications in women of childbearing age during pregnancy." | 1.48 | [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. ( Li, XY; Liu, XY; Zhao, JX, 2018) |
| "The rate of preeclampsia was much higher at quintile (Q) 5 of VAT depth (9." | 1.46 | Preeclampsia and Preterm Birth Associated With Visceral Adiposity in Early Pregnancy. ( Berger, H; Bujold, E; Connelly, PW; De Souza, LR; Park, AL; Ray, JG, 2017) |
| "Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is caused by antiphospholipid antibodies." | 1.46 | Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. ( Berghella, V; Bernabini, D; Dall'Asta, A; Eke, AC; Facchinetti, F; Ghi, T; Hoxha, A; Martinelli, P; Maruotti, GM; Monari, F; Rizzo, G; Rizzo, N; Roman, A; Ruffatti, A; Saccone, G; Sarno, L; Schuit, E; Simonazzi, G; Visentin, S; Xodo, S, 2017) |
| "Obstetrical APS with isolated recurrent miscarriages is mostly associated with isolated anticardiolipids antibodies and have better obstetrical outcome." | 1.46 | [Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?] ( Abisror, N; Bornes, M; Carbillon, L; Cohen, J; Fain, O; Josselin-Mahr, L; Kayem, G; Mekinian, A, 2017) |
| "In univariate analyses, treatment effect on pregnancy losses was similar in patients with APS and non-conventional APS, with odds ratio at 3." | 1.43 | Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies. ( Benbara, A; Bourrienne, MC; Carbillon, L; Chollet-Martin, S; Fain, O; Mekinian, A; Montestruc, F; Nicaise-Roland, P; Noémie, A; Tigaizin, A, 2016) |
| "The number of cases of aPL-related pregnancy complications that physicians have intervened was relatively small." | 1.42 | The participations of the physicians on the diagnosis and treatments of antiphospholipid related pregnancy morbidities in Japan: from the result of nationwide survey. ( Amengual, O; Atsumi, T; Bohgaki, T; Horita, T; Kaneko, K; Murashima, A; Nakanishi, I; Nozawa, K; Oku, K; Oomura, K; Sugiura-Ogasawara, M; Yasuda, S, 2015) |
| "(2) Influence of treatment on the pregnancy outcomes and complications: 24 APS patients were given the treatment of aspirin or aspirin combined with low molecular weight heparin, and 30 patients received no treatment." | 1.40 | [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study]. ( Deng, XL; Liu, XY; Zheng, XJ, 2014) |
| "Systemic lupus erythematosus is a chronic autoimmune disorder which affects women with child bearing potential." | 1.38 | [Successful completed pregnancies in patients with systemic lupus erythematosus]. ( Kiss, E; Szegedi, G; Tarr, T; Zeher, M, 2012) |
| "Eptifibatide was stopped for induction of labor." | 1.38 | Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction. ( Bauer, ME; Bauer, ST; Mhyre, JM; Rabbani, AB, 2012) |
| "The risk for preeclampsia increased in patients who were positive for multiple antiphospholipid antibodies (aPL) (odds ratio (OR) 3." | 1.38 | Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study. ( Brinks, R; Fischer-Betz, R; Schneider, M; Specker, C, 2012) |
| "Preterm birth was more frequent in study group than general population (21." | 1.38 | Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility. ( Ahn, H; Beaman, K; Gilman-Sachs, A; Han, AR; Kwak-Kim, J; Park, JC; Vu, P, 2012) |
| "Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral paralysis of the diaphragm." | 1.37 | Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome. ( Brost, BC; DeStephano, CC; Meena, M; Watson, WJ, 2011) |
| "Treatment with aspirin and LMWH is associated with improved outcomes for women with previous late fetal loss or early delivery due to placental dysfunction (Group 2)." | 1.36 | Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. ( Bewley, S; Bramham, K; Calatayud, I; Germain, S; Hunt, BJ; Khamashta, M; Nelson-Piercy, C, 2010) |
| "Thus, in order to diagnose and treat pregnancy-triggered APS in patients with unexplained recurrent miscarriage, screening for APL should also be performed at several time points after conception." | 1.36 | Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages. ( Engel, JB; Häusler, S; Honig, A; Kranke, P; Segerer, SE; Würfel, W, 2010) |
| "The pregnancy was uneventful and the delivery at term." | 1.36 | Treatment of cobalamin C (cblC) deficiency during pregnancy. ( Brunel-Guitton, C; Costa, T; Lambert, M; Mitchell, GA, 2010) |
| "The occurrence of superimposed preeclampsia should be detected by appropriate clinical and laboratory evaluation." | 1.35 | [Arterial hypertension in pregnancy]. ( Leeman, M, 2008) |
| "Between 20% and 40% of patients with systemic lupus erythematosus (SLE) have positive blood tests for antiphospholipid antibodies (aPLs)." | 1.35 | How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. ( Giles, I; Rahman, A, 2009) |
| "21/29, 72." | 1.35 | Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry. ( Candoni, A; Cascavilla, N; Cedrone, M; Ciancia, R; Comitini, G; Gugliotta, L; Latagliata, R; Martinelli, V; Martino, B; Melillo, L; Palmieri, F; Radaelli, F; Scalzulli, PR; Specchia, G; Tieghi, A; Usala, E; Valente, D; Valvano, MR, 2009) |
| "Antiphospholipid syndrome is a recognized disorder of pregnancy." | 1.33 | Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up. ( Khurshid, M; Naru, T; Nazir, Z, 2006) |
| "Autoimmune diseases are a group of illnesses in which autoantibodies are produced against various organs, presenting with a variety of clinical symptoms." | 1.32 | Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage. ( Chen, L; Miller, RK; Ornoy, A; Silver, RM, 2004) |
| "Acute fatty liver is a rare but fatal complication of pregnancy." | 1.32 | Acute fatty liver of pregnancy after aspirin intake. ( Deren, O; Durukan, T; Kizilkiliç-Parlakgümüş, A; Onderoğlu, L; Saygan-Karamürsel, B, 2004) |
| "Previous studies of gastroschisis have suggested that risk is increased for maternal use of vasoactive over-the-counter medications, including specific analgesics and decongestants." | 1.31 | Maternal medication use and risks of gastroschisis and small intestinal atresia. ( Mitchell, AA; Sheehan, JE; Werler, MM, 2002) |
| "Pregnancy was authorized if disease was inactive on 20 mg/day prednisone or less for at least 1 yr." | 1.30 | Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. ( Blétry, O; Darbois, Y; Godeau, P; Lê Huong, D; Lefèbvre, G; Piette, JC; Seebacher, J; Vauthier-Brouzes, D; Wechsler, B, 1997) |
| "Patients with antiphospholipid syndrome are at high risk of pregnancy loss as well as maternal morbidity, especially thrombo-embolic disease." | 1.30 | Obstetric outcome in antiphospholipid syndrome. ( Farquharson, RG; Granger, KA, 1997) |
| "Pulmonary edema was rare and acute renal failure did not develop in any women." | 1.30 | Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. ( Caritis, SN; Dombrowski, MP; Hauth, JC; Hogg, B; Klebanoff, M; Landon, M; Lindheimer, M; MacPherson, C; McNellis, D; Meis, PJ; Miodovnik, M; Paul, R; Roberts, JM; Sibai, BM; Thurnau, GR; Van Dorsten, JP, 1999) |
| "The patient had experienced hepatic infarction during her first pregnancy and had repeated hepatic infarction during her third pregnancy." | 1.29 | Hepatic infarction during pregnancy complicated by antiphospholipid syndrome. ( Kinoshita, K, 1993) |
| "Women on aspirin, who developed preeclampsia, delivered later in pregnancy [35." | 1.29 | Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. ( Fairley, KF; Ferrier, C; Gamble, G; Kincaid-Smith, P; North, RA, 1995) |
| "Two patients had systemic lupus erythematosus, and the other five fulfilled criteria for the primary antiphospholipid syndrome." | 1.28 | Fetal loss treatment in patients with antiphospholipid antibodies. ( Barquinero, J; Genover, E; Jordana, R; Ordi, J; Selva, A; Tolosa, C; Vilardell, M, 1989) |
| "After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 1.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
| "A clinical diagnosis of systemic lupus erythematosus (SLE) was made in four women." | 1.27 | Lupus anticoagulant in pregnancy. ( Butler, WS; Liggins, GC; Lubbe, WF; Palmer, SJ, 1984) |
| "In patients with preeclampsia the renal excretion of beta 2-microglobulin allows to differentiate between a primary preeclampsia and a preeclampsia superimposed upon chronic pyelonephritis." | 1.26 | Beta 2-microglobulin and other proteins as parameter for tubular function. ( Jaques, G; Keller, M; Mondorf, AW; Prüfer, D; Weise, M, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (12.23) | 18.7374 |
| 1990's | 89 (24.18) | 18.2507 |
| 2000's | 88 (23.91) | 29.6817 |
| 2010's | 115 (31.25) | 24.3611 |
| 2020's | 31 (8.42) | 2.80 |
| Authors | Studies |
|---|---|
| Rudolph, JE | 1 |
| Cartus, A | 1 |
| Bodnar, LM | 2 |
| Schisterman, EF | 7 |
| Naimi, AI | 2 |
| Mkhize, PZ | 1 |
| Phoswa, WN | 1 |
| Khaliq, OP | 1 |
| Dorsamy, V | 1 |
| Moodley, J | 1 |
| Ray, JG | 2 |
| Abdulaziz, KE | 1 |
| Berger, H | 2 |
| Ortiz-Basso, T | 1 |
| Gomez, PV | 1 |
| Boffelli, A | 1 |
| Paladini, A | 1 |
| Fu, Z | 1 |
| Ding, X | 1 |
| Wei, D | 1 |
| Li, J | 1 |
| Cang, R | 1 |
| Li, X | 2 |
| Silver, R | 1 |
| Craigo, S | 1 |
| Porter, F | 1 |
| Osmundson, SS | 1 |
| Kuller, JA | 1 |
| Norton, ME | 1 |
| He, S | 3 |
| Liang, L | 1 |
| Phillips, J | 3 |
| Nathan, E | 3 |
| Graham, D | 3 |
| Lim, S | 2 |
| McDougall, ARA | 1 |
| Goldstein, M | 1 |
| Tuttle, A | 1 |
| Hastie, R | 1 |
| Tong, S | 1 |
| Ammerdorffer, A | 1 |
| Rushwan, S | 1 |
| Ricci, C | 1 |
| Gülmezoglu, AM | 1 |
| Vogel, JP | 1 |
| Mendoza, M | 1 |
| Bonacina, E | 1 |
| Garcia-Manau, P | 1 |
| López, M | 1 |
| Caamiña, S | 1 |
| Vives, À | 1 |
| Lopez-Quesada, E | 1 |
| Ricart, M | 1 |
| Maroto, A | 1 |
| de Mingo, L | 1 |
| Pintado, E | 1 |
| Ferrer-Costa, R | 1 |
| Martin, L | 1 |
| Rodríguez-Zurita, A | 1 |
| Garcia, E | 1 |
| Pallarols, M | 1 |
| Vidal-Sagnier, L | 1 |
| Teixidor, M | 1 |
| Orizales-Lago, C | 1 |
| Pérez-Gomez, A | 1 |
| Ocaña, V | 1 |
| Puerto, L | 1 |
| Millán, P | 1 |
| Alsius, M | 1 |
| Diaz, S | 1 |
| Maiz, N | 1 |
| Carreras, E | 1 |
| Suy, A | 1 |
| Tao, JJ | 1 |
| Adurty, S | 1 |
| D'Angelo, D | 1 |
| DeSancho, MT | 2 |
| Lazzaroni, MG | 2 |
| Fredi, M | 2 |
| Andreoli, L | 5 |
| Chighizola, CB | 5 |
| Del Ross, T | 4 |
| Gerosa, M | 5 |
| Kuzenko, A | 1 |
| Raimondo, MG | 2 |
| Lojacono, A | 2 |
| Ramazzotto, F | 1 |
| Zatti, S | 2 |
| Trespidi, L | 3 |
| Meroni, PL | 4 |
| Pengo, V | 3 |
| Ruffatti, A | 8 |
| Tincani, A | 10 |
| Alijotas-Reig, J | 4 |
| Esteve-Valverde, E | 2 |
| Ferrer-Oliveras, R | 3 |
| Sáez-Comet, L | 2 |
| Lefkou, E | 3 |
| Mekinian, A | 5 |
| Belizna, C | 3 |
| Hoxha, A | 7 |
| Nalli, C | 1 |
| Marozio, L | 2 |
| Maina, A | 1 |
| Espinosa, G | 3 |
| Ríos-Garcés, R | 2 |
| Cervera, R | 6 |
| Carolis, S | 1 |
| Monteleone, G | 1 |
| Latino, O | 2 |
| Udry, S | 3 |
| LLurba, E | 2 |
| Garrido-Gimenez, C | 1 |
| Rovere-Querini, P | 3 |
| Canti, V | 3 |
| Mayer-Pickel, K | 2 |
| Tabacco, S | 2 |
| Arnau, A | 2 |
| Trapé, J | 2 |
| Ruiz-Hidalgo, D | 2 |
| Sos, L | 2 |
| Farran-Codina, I | 2 |
| Maze, D | 1 |
| Kazi, S | 1 |
| Gupta, V | 1 |
| Malinowski, AK | 1 |
| Fazelzad, R | 1 |
| Shah, PS | 1 |
| Shehata, N | 1 |
| Favaro, M | 3 |
| Calligaro, A | 3 |
| Ruffatti, AT | 2 |
| Infantolino, C | 1 |
| Tonello, M | 4 |
| Mattia, E | 1 |
| Jacobson, B | 1 |
| Rambiritch, V | 1 |
| Paek, D | 1 |
| Sayre, T | 1 |
| Naidoo, P | 1 |
| Shan, J | 1 |
| Leisegang, R | 1 |
| Mirzakhani, H | 1 |
| McElrath, TF | 1 |
| Weiss, ST | 1 |
| Voutetakis, A | 1 |
| Pervanidou, P | 1 |
| Kanaka-Gantenbein, C | 1 |
| Eudy, AM | 1 |
| Voora, D | 1 |
| Myers, RA | 1 |
| Clowse, MEB | 1 |
| Arslan, E | 1 |
| Branch, DW | 6 |
| Radin, M | 2 |
| Cecchi, I | 1 |
| Schreiber, K | 5 |
| Rubini, E | 1 |
| Roccatello, D | 2 |
| Cuadrado, MJ | 2 |
| Sciascia, S | 5 |
| Russo, LM | 1 |
| Whitcomb, BW | 1 |
| Freeman, JR | 1 |
| Mumford, SL | 6 |
| Sjaarda, LA | 4 |
| Perkins, NJ | 5 |
| Schliep, KC | 1 |
| Grewal, J | 1 |
| Silver, RM | 8 |
| Pregnolato, F | 1 |
| Comerio, C | 1 |
| Bartoli, F | 1 |
| Lonati, PA | 1 |
| Borghi, MO | 1 |
| Acaia, B | 1 |
| Ossola, MW | 1 |
| Ferrazzi, E | 1 |
| Skeith, L | 1 |
| Blondon, M | 1 |
| Ní Áinle, F | 1 |
| Rolnik, DL | 3 |
| Nicolaides, KH | 4 |
| Poon, LC | 3 |
| Latino, JO | 2 |
| Aranda, F | 1 |
| Wingeyer, SP | 1 |
| Romero, DSF | 1 |
| Larrañaga, G | 1 |
| Varoudi, K | 1 |
| Pombo, J | 1 |
| Jurisic, A | 1 |
| Jurisic, Z | 1 |
| Contento, G | 1 |
| Girardi, G | 1 |
| Gangat, N | 1 |
| Tefferi, A | 2 |
| Zhang, Y | 1 |
| Shen, F | 1 |
| Yang, W | 1 |
| Wang, J | 2 |
| Zhou, J | 1 |
| Chen, Y | 1 |
| Gervasi, MT | 1 |
| Bouvier, S | 2 |
| Fortier, M | 1 |
| Vincent, L | 1 |
| Demattei, C | 1 |
| Mousty, E | 2 |
| Herzog, M | 1 |
| Rommelaere, G | 1 |
| Nouvellon, E | 1 |
| Mercier, E | 2 |
| Letouzey, V | 2 |
| Gris, JC | 2 |
| Khizroeva, J | 2 |
| Bitsadze, V | 2 |
| Makatsariya, A | 2 |
| Arslanbekova, M | 1 |
| Babaeva, N | 1 |
| Tsibizova, V | 1 |
| Shkoda, A | 1 |
| Makatsariya, N | 1 |
| Tretyakova, M | 1 |
| Solopova, A | 1 |
| Gadaeva, Z | 1 |
| Vorobev, A | 1 |
| Khamani, I | 1 |
| Aslanova, Z | 1 |
| Nakaidze, I | 1 |
| Mischenko, A | 1 |
| Grigoreva, K | 1 |
| Kunesko, N | 1 |
| Egorova, E | 1 |
| Mashkova, T | 1 |
| Shopit, A | 1 |
| Riancho-Zarrabeitia, L | 1 |
| Daroca, G | 1 |
| Muñoz, P | 1 |
| López-Hoyos, M | 1 |
| Haya, A | 1 |
| Martínez-Taboada, VM | 1 |
| Wright, D | 2 |
| O'Gorman, N | 1 |
| Syngelaki, A | 2 |
| de Paco Matallana, C | 1 |
| Akolekar, R | 2 |
| Cicero, S | 1 |
| Janga, D | 1 |
| Singh, M | 1 |
| Molina, FS | 1 |
| Persico, N | 2 |
| Jani, JC | 2 |
| Plasencia, W | 2 |
| Papaioannou, G | 1 |
| Tenenbaum-Gavish, K | 1 |
| Meiri, H | 1 |
| Gizurarson, S | 1 |
| Maclagan, K | 1 |
| Iriye, BK | 1 |
| Gregory, KD | 1 |
| Saade, GR | 1 |
| Grobman, WA | 1 |
| Brown, HL | 1 |
| Delgado, JL | 1 |
| Tsokaki, T | 1 |
| Leipold, G | 1 |
| Shearing, S | 1 |
| De Stefani, L | 1 |
| Evangelinakis, N | 1 |
| Gonzalez-Vanegas, O | 1 |
| Connell, MT | 1 |
| Radin, RG | 2 |
| Kuhr, D | 1 |
| Plowden, TC | 1 |
| Quao, ZC | 1 |
| Tong, M | 1 |
| Bryce, E | 1 |
| Guller, S | 1 |
| Chamley, LW | 3 |
| Abrahams, VM | 2 |
| Bohîlţea, RE | 1 |
| Cîrstoiu, MM | 1 |
| Ionescu, CA | 1 |
| Niculescu-Mizil, E | 1 |
| Vlădăreanu, AM | 1 |
| Voican, I | 1 |
| Dimitriu, M | 1 |
| Turcan, N | 1 |
| Chen, WL | 1 |
| Liu, YD | 1 |
| Li, XL | 1 |
| Feng, SX | 1 |
| Zhou, XY | 1 |
| Ma, WX | 1 |
| Li, Y | 2 |
| Ye, DS | 1 |
| Chen, X | 2 |
| Chen, SL | 1 |
| de Groot, PG | 2 |
| Devreese, K | 1 |
| Jacobsen, S | 3 |
| Ruiz-Irastorza, G | 7 |
| Salmon, JE | 2 |
| Shoenfeld, Y | 5 |
| Shovman, O | 1 |
| Hunt, BJ | 5 |
| Aggogeri, E | 1 |
| Bettiga, E | 1 |
| Le Guern, V | 2 |
| Morel, N | 1 |
| Piette, JC | 3 |
| Costedoat-Chalumeau, N | 2 |
| Oh, J | 1 |
| Bae, JY | 1 |
| de Moreuil, C | 1 |
| Fauchais, AL | 1 |
| Merviel, P | 2 |
| Tremouilhac, C | 1 |
| Le Moigne, E | 1 |
| Pasquier, E | 1 |
| Pan-Petesch, B | 1 |
| Lacut, K | 1 |
| Akinshina, S | 1 |
| Khamani, N | 1 |
| Gerardi, MC | 1 |
| Fernandes, MA | 1 |
| Sutton, EF | 1 |
| Hauspurg, A | 1 |
| Caritis, SN | 2 |
| Powers, RW | 1 |
| Catov, JM | 1 |
| Cunningham, TK | 1 |
| Draper, H | 1 |
| Rajesh, U | 1 |
| Kemp, M | 1 |
| Thomas, W | 1 |
| Placais, L | 1 |
| Carrat, F | 1 |
| Carbillon, L | 3 |
| Nicaise Roland, P | 1 |
| Benbara, A | 2 |
| Cacciatore, C | 1 |
| Fain, O | 3 |
| Li, XY | 1 |
| Zhao, JX | 1 |
| Liu, XY | 2 |
| Mendel, A | 1 |
| Bernatsky, SB | 1 |
| Hanly, JG | 1 |
| Urowitz, MB | 1 |
| Clarke, AE | 1 |
| Romero-Diaz, J | 1 |
| Gordon, C | 2 |
| Bae, SC | 1 |
| Wallace, DJ | 1 |
| Merrill, JT | 2 |
| Buyon, JP | 1 |
| Isenberg, DA | 1 |
| Rahman, A | 3 |
| Ginzler, EM | 1 |
| Petri, M | 1 |
| Dooley, MA | 1 |
| Fortin, PR | 1 |
| Gladman, DD | 1 |
| Steinsson, K | 1 |
| Ramsey-Goldman, R | 2 |
| Khamashta, MA | 8 |
| Aranow, C | 1 |
| Mackay, M | 1 |
| Alarcón, GS | 1 |
| Manzi, S | 2 |
| Nived, O | 1 |
| Jönsen, A | 1 |
| Zoma, AA | 1 |
| van Vollenhoven, RF | 1 |
| Ramos-Casals, M | 1 |
| Kalunian, KC | 1 |
| Inanc, M | 1 |
| Kamen, DL | 1 |
| Peschken, CA | 1 |
| Askanase, A | 1 |
| Sanchez-Guerrero, J | 1 |
| Bruce, IN | 1 |
| Vinet, É | 1 |
| Atallah, A | 1 |
| Lecarpentier, E | 1 |
| Goffinet, F | 2 |
| Gaucherand, P | 1 |
| Doret-Dion, M | 1 |
| Tsatsaris, V | 1 |
| De Carolis, S | 2 |
| Lundelin, K | 1 |
| Reshetnyak, T | 1 |
| Stojanovich, L | 1 |
| Gogou, V | 1 |
| Varoudis, A | 1 |
| Stoppani, C | 1 |
| Martí-Cañamares, A | 1 |
| Huang, J | 1 |
| Xing, H | 1 |
| Chen, L | 2 |
| Xie, Z | 1 |
| Wang, X | 1 |
| Cui, H | 1 |
| Chen, J | 1 |
| Boulanger, H | 1 |
| Lefèvre, G | 2 |
| Ahriz Saksi, S | 1 |
| Achiche, J | 1 |
| Bailleul, S | 1 |
| Ekoukou, D | 1 |
| Drouin, D | 1 |
| Sault, C | 1 |
| Stawiarski, N | 1 |
| Dupuis, E | 1 |
| Nobles, CJ | 1 |
| Mendola, P | 1 |
| Kim, K | 1 |
| Sjaarda, L | 1 |
| Hill, M | 1 |
| Leavitt, K | 1 |
| Običan, S | 1 |
| Yankowitz, J | 1 |
| Hui, D | 1 |
| Hladunewich, MA | 1 |
| Hassan, SS | 1 |
| Gomez-Lopez, N | 1 |
| Patel, V | 1 |
| Ramachandran, B | 1 |
| Omar, I | 1 |
| Visentin, MS | 2 |
| Punzi, L | 1 |
| Soh, MC | 1 |
| Pasupathy, D | 1 |
| Gray, G | 1 |
| Nelson-Piercy, C | 3 |
| Khazardoost, S | 1 |
| Mousavi, S | 1 |
| Borna, S | 1 |
| Hantoushzadeh, S | 1 |
| Alavi, A | 1 |
| Khezerlou, N | 1 |
| Bertolaccini, ML | 1 |
| Seed, PT | 3 |
| Tektonidou, MG | 1 |
| Aguirre, A | 1 |
| Mico, L | 1 |
| Egurbide, MV | 2 |
| Gil, A | 1 |
| Houssiau, F | 1 |
| Martin, H | 1 |
| McHugh, N | 1 |
| Galindo, M | 1 |
| Akil, M | 1 |
| Amigo, MC | 1 |
| Murru, V | 1 |
| Chapin, J | 1 |
| Carlson, K | 1 |
| Christos, PJ | 1 |
| de Jesús, GR | 1 |
| Rodrigues, G | 1 |
| de Jesús, NR | 1 |
| Levy, RA | 2 |
| Yasuda, S | 2 |
| Gaul, C | 1 |
| Kutteh, WH | 7 |
| Hinote, CD | 1 |
| Lesher, LL | 2 |
| Faraggi, D | 2 |
| Wactawski-Wende, J | 2 |
| Townsend, JM | 2 |
| Lynch, AM | 2 |
| Galai, N | 3 |
| Zheng, XJ | 1 |
| Deng, XL | 1 |
| Bujold, E | 5 |
| Roberge, S | 4 |
| Demers, S | 2 |
| Abramovici, A | 1 |
| Jauk, V | 1 |
| Wetta, L | 1 |
| Cantu, J | 1 |
| Edwards, R | 1 |
| Biggio, J | 1 |
| Tita, A | 1 |
| Mutlu, I | 1 |
| Mutlu, MF | 1 |
| Biri, A | 1 |
| Bulut, B | 1 |
| Erdem, M | 1 |
| Erdem, A | 1 |
| Arachchillage, DR | 1 |
| Machin, SJ | 1 |
| Mackie, IJ | 1 |
| Cohen, H | 4 |
| Nizamuddin, SL | 1 |
| Broderick, DK | 1 |
| Minehart, RD | 1 |
| Kamdar, BB | 1 |
| Holm, M | 1 |
| Msall, ME | 1 |
| Skranes, J | 1 |
| Dammann, O | 1 |
| Allred, E | 1 |
| Leviton, A | 2 |
| Jiang, N | 1 |
| Liu, Q | 1 |
| Liu, L | 1 |
| Yang, WW | 1 |
| Zeng, Y | 1 |
| Grandone, E | 2 |
| Villani, M | 1 |
| Tiscia, GL | 2 |
| Dimitrova, V | 1 |
| Dimitrov, R | 1 |
| Savov, A | 1 |
| Middeldorp, S | 2 |
| Pavord, S | 1 |
| Khamashta, M | 3 |
| Kattah, AG | 1 |
| Garovic, VD | 1 |
| Verbruggen, M | 1 |
| Mannaerts, D | 1 |
| Muys, J | 1 |
| Jacquemyn, Y | 1 |
| Bergeron, TS | 1 |
| Carpentier, C | 1 |
| Sibai, B | 1 |
| McCaw-Binns, A | 1 |
| Lykke, JA | 1 |
| Langhoff-Roos, J | 1 |
| Nielsen, HS | 1 |
| Truong, A | 1 |
| Sayago, MM | 1 |
| Ke, RW | 1 |
| Leon, MG | 1 |
| Moussa, HN | 1 |
| Longo, M | 1 |
| Pedroza, C | 1 |
| Haidar, ZA | 1 |
| Mendez-Figueroa, H | 1 |
| Blackwell, SC | 2 |
| Sibai, BM | 4 |
| Ahrens, KA | 1 |
| Zarek, S | 1 |
| Euser, AG | 1 |
| Metz, TD | 1 |
| Allshouse, AA | 1 |
| Heyborne, KD | 2 |
| Oku, K | 1 |
| Murashima, A | 2 |
| Oomura, K | 1 |
| Amengual, O | 1 |
| Bohgaki, T | 1 |
| Horita, T | 1 |
| Kaneko, K | 1 |
| Nakanishi, I | 1 |
| Nozawa, K | 1 |
| Sugiura-Ogasawara, M | 1 |
| Atsumi, T | 2 |
| Moroni, G | 1 |
| Ponticelli, C | 1 |
| Källén, B | 1 |
| Reis, M | 1 |
| Bourrienne, MC | 1 |
| Noémie, A | 1 |
| Chollet-Martin, S | 1 |
| Tigaizin, A | 1 |
| Montestruc, F | 1 |
| Nicaise-Roland, P | 1 |
| Costantine, MM | 1 |
| Hinkle, SN | 1 |
| Grantz, KL | 1 |
| Mitchell, EM | 1 |
| Herrera, CA | 1 |
| Heuser, CC | 1 |
| Gernand, AD | 1 |
| Simhan, HN | 1 |
| Baca, KM | 1 |
| Caritis, S | 1 |
| De Souza, LR | 1 |
| Park, AL | 1 |
| Connelly, PW | 1 |
| Cochery-Nouvellon, É | 1 |
| Balducchi, JP | 1 |
| Quéré, I | 1 |
| Perez-Martin, A | 1 |
| Alvarez, AM | 1 |
| Balcázar, N | 1 |
| San Martín, S | 1 |
| Markert, UR | 1 |
| Cadavid, AP | 1 |
| Song, Y | 1 |
| Wang, HY | 1 |
| Qiao, J | 1 |
| Liu, P | 1 |
| Chi, HB | 1 |
| Saccone, G | 1 |
| Berghella, V | 1 |
| Maruotti, GM | 1 |
| Ghi, T | 1 |
| Rizzo, G | 1 |
| Simonazzi, G | 1 |
| Rizzo, N | 1 |
| Facchinetti, F | 1 |
| Dall'Asta, A | 1 |
| Visentin, S | 1 |
| Sarno, L | 1 |
| Xodo, S | 1 |
| Bernabini, D | 1 |
| Monari, F | 1 |
| Roman, A | 1 |
| Eke, AC | 1 |
| Schuit, E | 1 |
| Martinelli, P | 1 |
| Aranda, FM | 1 |
| Perés Wingeyer, SDA | 1 |
| Fernández Romero, DS | 1 |
| de Larrañaga, GF | 1 |
| Kayem, G | 1 |
| Cohen, J | 1 |
| Abisror, N | 1 |
| Josselin-Mahr, L | 1 |
| Bornes, M | 1 |
| Casellas-Caro, M | 1 |
| Llurba-Olive, E | 1 |
| Hermosilla, E | 1 |
| Vilardell-Tarres, M | 1 |
| Cabero-Roura, L | 1 |
| Leeman, M | 1 |
| Dendrinos, S | 1 |
| Sakkas, E | 1 |
| Makrakis, E | 1 |
| d'Ythurbide, G | 1 |
| Rousset, P | 1 |
| Carbonne, B | 3 |
| Cabane, J | 2 |
| Fardet, L | 1 |
| Tiev, K | 1 |
| Kettaneh, A | 1 |
| Heilmann, L | 2 |
| Schorch, M | 1 |
| Hahn, T | 1 |
| Adasz, G | 1 |
| Schilberz, K | 1 |
| Adiguzel, C | 1 |
| Fareed, J | 1 |
| Martinez-Berriotxoa, A | 1 |
| Giles, I | 1 |
| Melillo, L | 1 |
| Tieghi, A | 1 |
| Candoni, A | 1 |
| Radaelli, F | 1 |
| Ciancia, R | 1 |
| Specchia, G | 1 |
| Martino, B | 1 |
| Scalzulli, PR | 1 |
| Latagliata, R | 1 |
| Palmieri, F | 1 |
| Usala, E | 1 |
| Valente, D | 1 |
| Valvano, MR | 1 |
| Cedrone, M | 1 |
| Comitini, G | 1 |
| Martinelli, V | 1 |
| Cascavilla, N | 1 |
| Gugliotta, L | 1 |
| Mo, D | 1 |
| Saravelos, S | 1 |
| Metwally, M | 1 |
| Makris, M | 1 |
| Li, TC | 1 |
| Passamonti, F | 1 |
| Bramham, K | 1 |
| Germain, S | 1 |
| Calatayud, I | 1 |
| Bewley, S | 1 |
| Mak, A | 1 |
| Cheung, MW | 1 |
| Cheak, AA | 1 |
| Ho, RC | 1 |
| Lim, W | 1 |
| Carp, HJ | 3 |
| Leroux, P | 1 |
| Hennebert, C | 1 |
| Catteau, J | 1 |
| Legros, H | 1 |
| Hennebert, O | 1 |
| Laudenbach, V | 1 |
| Marret, S | 1 |
| Gelber, SE | 1 |
| Campos-Outcalt, D | 1 |
| Calderon, AC | 1 |
| Berezowski, AT | 1 |
| Marcolin, AC | 1 |
| Martins, WP | 1 |
| Duarte, G | 1 |
| Cavalli, RC | 1 |
| A/Magid, YM | 1 |
| Elussein, EA | 1 |
| Omer, MM | 1 |
| Samaan, SI | 1 |
| A/Rahim, F | 1 |
| Adam, I | 1 |
| Ogishima, H | 1 |
| Ito, S | 1 |
| Tsutsumi, A | 1 |
| Sugihara, M | 1 |
| Goto, D | 1 |
| Matsumoto, I | 1 |
| Obata-Yasuoka, M | 1 |
| Hamada, H | 1 |
| Yoshikawa, H | 1 |
| Takahashi, H | 1 |
| Sumida, T | 1 |
| Cohn, DM | 1 |
| Goddijn, M | 1 |
| Korevaar, JC | 1 |
| Dawood, F | 1 |
| Farquharson, RG | 2 |
| Naru, T | 2 |
| Khan, RS | 1 |
| Ali, R | 1 |
| Honig, A | 1 |
| Engel, JB | 1 |
| Segerer, SE | 1 |
| Kranke, P | 1 |
| Häusler, S | 1 |
| Würfel, W | 1 |
| Brunel-Guitton, C | 1 |
| Costa, T | 1 |
| Mitchell, GA | 1 |
| Lambert, M | 2 |
| Young, G | 1 |
| Jewell, D | 2 |
| Fouda, UM | 1 |
| Sayed, AM | 1 |
| Abdou, AM | 1 |
| Ramadan, DI | 1 |
| Fouda, IM | 1 |
| Zaki, MM | 1 |
| Meena, M | 1 |
| DeStephano, CC | 1 |
| Watson, WJ | 1 |
| Brost, BC | 1 |
| Bacri, JL | 1 |
| Dubucquoi, S | 1 |
| Quemeneur, T | 1 |
| Caron, C | 1 |
| Launay, D | 1 |
| Houfflin-Debarge, V | 1 |
| Hachulla, E | 2 |
| Kyndt, X | 1 |
| Subtil, D | 2 |
| Hatron, PY | 3 |
| Bontadi, A | 1 |
| Botta, A | 1 |
| Salvi, S | 1 |
| Nuzzo, M | 2 |
| Mosca, M | 1 |
| Mitic, G | 1 |
| Bertero, MT | 1 |
| Boffa, MC | 1 |
| Wójtowicz, A | 1 |
| Undas, A | 1 |
| Huras, H | 1 |
| Musiał, J | 1 |
| Rytlewski, K | 1 |
| Reroń, A | 1 |
| Wilczak, M | 1 |
| Jach, R | 1 |
| Galarza-Maldonado, C | 1 |
| Kourilovitch, MR | 1 |
| Pérez-Fernández, OM | 1 |
| Gaybor, M | 1 |
| Cordero, C | 1 |
| Cabrera, S | 1 |
| Soroka, NF | 1 |
| Han, CS | 1 |
| Mulla, MJ | 1 |
| Brosens, JJ | 1 |
| Paidas, MJ | 1 |
| Lockwood, CJ | 1 |
| Ernest, JM | 1 |
| Marshburn, PB | 1 |
| Tormene, D | 1 |
| De Stefano, V | 1 |
| Tosetto, A | 1 |
| Palareti, G | 1 |
| Margaglione, M | 1 |
| Castaman, G | 1 |
| Rossi, E | 2 |
| Ciminello, A | 1 |
| Valdrè, L | 1 |
| Legnani, C | 1 |
| Bafunno, V | 1 |
| Carraro, S | 1 |
| Rodeghiero, F | 1 |
| Simioni, P | 1 |
| Tarr, T | 1 |
| Kiss, E | 1 |
| Szegedi, G | 1 |
| Zeher, M | 1 |
| Bauer, ME | 1 |
| Bauer, ST | 1 |
| Rabbani, AB | 1 |
| Mhyre, JM | 1 |
| Wijetilleka, S | 1 |
| Scoble, T | 1 |
| Ahmed, OM | 1 |
| Ahmed, RG | 1 |
| El-Gareib, AW | 1 |
| El-Bakry, AM | 1 |
| Abd El-Tawab, SM | 1 |
| Fischer-Betz, R | 1 |
| Specker, C | 1 |
| Brinks, R | 1 |
| Schneider, M | 1 |
| Han, AR | 1 |
| Ahn, H | 1 |
| Vu, P | 1 |
| Park, JC | 1 |
| Gilman-Sachs, A | 1 |
| Beaman, K | 1 |
| Kwak-Kim, J | 1 |
| Burdan, F | 1 |
| Starosławska, E | 1 |
| Szumiło, J | 1 |
| Dworzańska, A | 1 |
| Dworzański, W | 1 |
| Kubiatowski, T | 1 |
| Cendrowska-Pinkosz, M | 1 |
| Urbańczyk-Zawadzka, M | 1 |
| Specker, Ch | 1 |
| Becker, R | 1 |
| Keller, T | 1 |
| Kiesewetter, H | 1 |
| Fangerau, H | 1 |
| Bittner, U | 1 |
| Shaheen, SO | 1 |
| Newson, RB | 1 |
| Sherriff, A | 1 |
| Henderson, AJ | 1 |
| Heron, JE | 1 |
| Burney, PG | 1 |
| Golding, J | 1 |
| Rai, R | 4 |
| Regan, L | 4 |
| Stone, S | 2 |
| Parmar, K | 1 |
| Poston, L | 2 |
| Triolo, G | 1 |
| Ferrante, A | 1 |
| Ciccia, F | 1 |
| Accardo-Palumbo, A | 1 |
| Perino, A | 1 |
| Castelli, A | 1 |
| Giarratano, A | 1 |
| Licata, G | 1 |
| von Dadelszen, P | 1 |
| Kent, N | 1 |
| Kupferminc, MJ | 1 |
| Eldor, A | 1 |
| von Tempelhoff, GF | 1 |
| Pollow, K | 1 |
| Nasonov, EL | 1 |
| Kozer, E | 1 |
| Costei, AM | 1 |
| Boskovic, R | 1 |
| Nulman, I | 1 |
| Nikfar, S | 1 |
| Koren, G | 1 |
| Boda, Z | 1 |
| Schlammadinger, A | 1 |
| László, P | 1 |
| Lakos, G | 1 |
| Kerényi, A | 1 |
| Pfliegler, G | 1 |
| Rázsó, K | 1 |
| Pósán, E | 1 |
| Langford, K | 1 |
| Nanda, S | 1 |
| Agarwal, U | 1 |
| Sangwan, K | 1 |
| DARMAILLACQ, R | 1 |
| PELLET, C | 1 |
| LEROY, P | 1 |
| EARLEY, PA | 1 |
| HAYDEN, J | 1 |
| Abraitis, V | 1 |
| Mongirdiene, A | 1 |
| Mockeviciene, A | 1 |
| Desvaux, D | 1 |
| Haddad, B | 1 |
| Blickstein, D | 1 |
| Hod, M | 1 |
| Bar, J | 1 |
| Chernev, T | 1 |
| Koleva, R | 1 |
| Karag'ozova, Zh | 1 |
| Chernev, A | 1 |
| Malinowski, A | 1 |
| Dyński, MA | 1 |
| Maciołek-Blewniewska, G | 1 |
| Głowacka, E | 1 |
| Pawłowski, T | 1 |
| Babula, G | 1 |
| Østensen, ME | 1 |
| Skomsvoll, JF | 1 |
| Allais, G | 1 |
| Bosio, A | 1 |
| Mana, O | 1 |
| Airola, G | 1 |
| Ciochetto, D | 1 |
| Terzi, MG | 1 |
| De Lorenzo, C | 1 |
| Quirico, PE | 1 |
| Benedetto, C | 1 |
| Bats, AS | 1 |
| Lejeune, V | 1 |
| Cynober, E | 3 |
| Safar, E | 1 |
| Gonzales, M | 1 |
| Milliez, J | 2 |
| Ornoy, A | 1 |
| Miller, RK | 1 |
| Stephenson, MD | 2 |
| Ballem, PJ | 1 |
| Tsang, P | 1 |
| Purkiss, S | 1 |
| Ensworth, S | 1 |
| Houlihan, E | 1 |
| Ensom, MH | 1 |
| Saygan-Karamürsel, B | 1 |
| Kizilkiliç-Parlakgümüş, A | 1 |
| Deren, O | 1 |
| Onderoğlu, L | 1 |
| Durukan, T | 1 |
| Kurdi, W | 1 |
| Fayyad, A | 1 |
| Thakur, V | 1 |
| Harrington, K | 1 |
| Balasch, J | 4 |
| Soy, M | 1 |
| Sayin, NC | 1 |
| Unlü, E | 1 |
| Noble, LS | 1 |
| Lashey, N | 1 |
| Franklin, RD | 1 |
| Herrada, J | 1 |
| Tzafettas, J | 1 |
| Petropoulos, P | 1 |
| Psarra, A | 1 |
| Delkos, D | 1 |
| Papaloukas, C | 1 |
| Giannoulis, H | 1 |
| Kalogiros, G | 1 |
| Gkoutzioulis, F | 1 |
| Bonaminio, PN | 1 |
| de Regnier, R | 1 |
| Chang, E | 1 |
| Day, N | 1 |
| Ng, HJ | 1 |
| Crowther, MA | 1 |
| San Miguel-Moncín, M | 1 |
| Cisteró-Bahíma, A | 1 |
| Wu, S | 1 |
| Faivre, L | 1 |
| Meerpohl, J | 1 |
| Da Costa, L | 1 |
| Marie, I | 1 |
| Nouvel, C | 1 |
| Gnekow, A | 1 |
| Bender-Götze, C | 1 |
| Bauters, F | 1 |
| Coiffier, B | 1 |
| Peaud, PY | 1 |
| Rispal, P | 1 |
| Berrebi, A | 1 |
| Berger, C | 1 |
| Flesch, M | 1 |
| Sagot, P | 3 |
| Varet, B | 1 |
| Niemeyer, C | 1 |
| Tchernia, G | 1 |
| Leblanc, T | 1 |
| Khurshid, M | 1 |
| Nazir, Z | 1 |
| Dolitzky, M | 1 |
| Inbal, A | 1 |
| Segal, Y | 1 |
| Weiss, A | 1 |
| Brenner, B | 1 |
| Carp, H | 1 |
| Karowicz-Bilińska, A | 1 |
| Kuś, E | 1 |
| Kowalska-Koprek, U | 1 |
| Boog, G | 2 |
| Le Vaillant, C | 1 |
| Alnoukari, F | 1 |
| Jossic, F | 1 |
| Barrier, J | 2 |
| Muller, JY | 2 |
| Hender, J | 1 |
| Harris, D | 1 |
| Richard, B | 1 |
| Dawson, A | 1 |
| Khanna, P | 1 |
| Mégarbane, B | 1 |
| Baud, F | 1 |
| Kornacka, MK | 1 |
| Bokiniec, R | 1 |
| Skrzypczak, J | 1 |
| Derksen, RH | 1 |
| Aguilera, C | 1 |
| Agustí, A | 1 |
| Richter, ON | 1 |
| Rath, W | 1 |
| Glasnović, M | 1 |
| Bosnjak, I | 1 |
| Vcev, A | 1 |
| Soldo, I | 1 |
| Kosuta, M | 1 |
| Lenz, B | 1 |
| Glasnović-Horvatić, E | 1 |
| Soldo-Butković, S | 1 |
| Mićunović, N | 1 |
| Macé, G | 1 |
| James, AH | 1 |
| Brancazio, LR | 1 |
| Price, T | 1 |
| Trakakis, E | 1 |
| Loghis, C | 1 |
| Laggas, D | 1 |
| Simeonides, G | 1 |
| Vaggopoulos, V | 1 |
| Chrelias, C | 1 |
| Lambos, G | 1 |
| Kassanos, D | 1 |
| Doria, A | 1 |
| Bajocchi, G | 1 |
| Tonon, M | 1 |
| Salvarani, C | 1 |
| Erkan, D | 1 |
| Patel, S | 1 |
| Lockshin, MD | 2 |
| Weise, M | 1 |
| Prüfer, D | 1 |
| Jaques, G | 1 |
| Keller, M | 1 |
| Mondorf, AW | 1 |
| Fahrländer, H | 1 |
| Spector, SL | 1 |
| Syrop, CH | 1 |
| Varner, MW | 1 |
| Niederhoff, H | 1 |
| Zahradnik, HP | 1 |
| Lubbe, WF | 3 |
| Walker, EB | 1 |
| Butler, WS | 1 |
| Palmer, SJ | 1 |
| Liggins, GC | 2 |
| Mishell, DR | 1 |
| Fisher, HW | 1 |
| Haynes, PJ | 1 |
| Jones, GS | 1 |
| Smith, RP | 1 |
| Gibbs, CJ | 1 |
| Coutts, II | 1 |
| Lock, R | 1 |
| Finnegan, OC | 1 |
| White, RJ | 1 |
| Stein, GH | 1 |
| Cantor, B | 1 |
| Panush, RS | 1 |
| Jackowski, L | 1 |
| Nowakowski, T | 1 |
| Sokal, K | 1 |
| Sadłecki, W | 1 |
| Mikhaĭlenko, ET | 1 |
| Chernega, MIa | 1 |
| Machlin, LJ | 1 |
| Gabriel, E | 1 |
| Horn, LR | 1 |
| Woo, D | 1 |
| Filipski, R | 1 |
| Brin, M | 1 |
| Nelson, J | 1 |
| Wenstrom, KD | 1 |
| Hauth, JC | 2 |
| Goldenberg, RL | 1 |
| DuBard, MB | 1 |
| Lea, C | 1 |
| Sasa, H | 2 |
| Aoki, K | 4 |
| Ogasawara, M | 3 |
| Kajiura, S | 1 |
| Yagami, Y | 1 |
| Hayashi, Y | 1 |
| Radermecker, M | 1 |
| Hamed, MR | 1 |
| al-Assy, YS | 1 |
| Ezzeldin, E | 1 |
| Christiansen, OB | 1 |
| Lauritsen, JG | 1 |
| Arnout, J | 1 |
| Spitz, B | 1 |
| Wittevrongel, C | 1 |
| Vanrusselt, M | 1 |
| Van Assche, A | 1 |
| Vermylen, J | 1 |
| Bremer, HA | 2 |
| Wallenburg, HC | 2 |
| Fletcher, HM | 1 |
| Wharfe, GH | 1 |
| Thomas, E | 2 |
| Schneider, H | 1 |
| Silveira, LH | 1 |
| Espinoza, LR | 1 |
| Silver, RK | 2 |
| MacGregor, SN | 1 |
| Sholl, JS | 1 |
| Hobart, JM | 1 |
| Neerhof, MG | 1 |
| Ragin, A | 1 |
| Karlowicz, MG | 1 |
| White, LE | 1 |
| Edelman, P | 1 |
| Ferris, AM | 1 |
| Reece, EA | 2 |
| Gatenby, P | 1 |
| Kinoshita, K | 1 |
| Stuart, RA | 1 |
| Quinn, MJ | 1 |
| McHugh, NJ | 1 |
| Fiks-Sigaud, M | 1 |
| Audrain, M | 1 |
| Ngo, VU | 1 |
| Kammoun, M | 1 |
| Bouzaghar, A | 1 |
| Saranti, L | 1 |
| Jeny, R | 1 |
| Rogov, VA | 2 |
| Tareeva, IE | 1 |
| Sidorova, IS | 1 |
| Androsova, SO | 1 |
| Katamadze, KT | 1 |
| Nikiforova, OV | 2 |
| Kaaja, R | 2 |
| Julkunen, H | 2 |
| Ammälä, P | 1 |
| Palosuo, T | 1 |
| Kurki, P | 1 |
| Menashe, Y | 2 |
| Ben-Baruch, G | 1 |
| Greenspoon, JS | 1 |
| Rosen, DJ | 1 |
| Mashiach, S | 2 |
| Many, A | 3 |
| O'Connell, PD | 1 |
| Caplan, MS | 1 |
| Viinikka, L | 1 |
| Ylikorkala, O | 1 |
| Chakravarty, K | 1 |
| Merry, P | 1 |
| Itoh, H | 1 |
| Ihara, Y | 1 |
| Hasegawa, M | 1 |
| Okagaki, A | 1 |
| Inamori, K | 1 |
| Sagawa, N | 1 |
| Mori, T | 1 |
| Mandai, M | 1 |
| Niwa, H | 1 |
| Buck, ML | 1 |
| Grebe, TA | 1 |
| Bond, GR | 1 |
| Fishman, P | 1 |
| Van Marter, LJ | 1 |
| Allred, EN | 1 |
| Pagano, M | 1 |
| Sullivan, KF | 1 |
| Cohen, A | 1 |
| Epstein, MF | 1 |
| Grant, JM | 1 |
| Fahy, BG | 1 |
| Malinow, AM | 1 |
| North, RA | 1 |
| Ferrier, C | 1 |
| Gamble, G | 1 |
| Fairley, KF | 1 |
| Kincaid-Smith, P | 1 |
| Kozlovskaia, NL | 1 |
| Zozulia, OV | 1 |
| Miroshnichenko, NG | 1 |
| Leslie, GI | 1 |
| Gallery, ED | 1 |
| Arnold, JD | 1 |
| Ross, MR | 1 |
| Gyory, AZ | 1 |
| Theis, JG | 1 |
| Mackworth-Young, C | 1 |
| Dave, M | 1 |
| el Kouri, D | 1 |
| Winer, N | 1 |
| Hamidou, M | 1 |
| Cowchock, S | 1 |
| Botet, F | 1 |
| Romera, G | 1 |
| Montagut, P | 1 |
| Figueras, J | 1 |
| Carmona, F | 2 |
| Laskin, CA | 1 |
| Bombardier, C | 1 |
| Hannah, ME | 1 |
| Mandel, FP | 1 |
| Ritchie, JW | 1 |
| Farewell, V | 1 |
| Farine, D | 1 |
| Spitzer, K | 1 |
| Fielding, L | 1 |
| Soloninka, CA | 1 |
| Yeung, M | 1 |
| Lê Huong, D | 1 |
| Wechsler, B | 2 |
| Vauthier-Brouzes, D | 1 |
| Seebacher, J | 1 |
| Lefèbvre, G | 1 |
| Blétry, O | 2 |
| Darbois, Y | 1 |
| Godeau, P | 1 |
| Granger, KA | 1 |
| Faas, MM | 1 |
| Schuiling, GA | 1 |
| Baller, JF | 1 |
| Valkhof, N | 1 |
| Bakker, WW | 1 |
| Rojas-Poceros, G | 1 |
| Ramírez Peredo, J | 1 |
| Hernández Andrade, E | 1 |
| Bustos López, HH | 1 |
| Monastiri, K | 1 |
| Chaieb, A | 1 |
| Skouri, H | 1 |
| Slama, A | 1 |
| Chebil, S | 1 |
| Maaroufi, R | 1 |
| Nouira, M | 1 |
| Mokni, M | 1 |
| Zanina, R | 1 |
| Saidi, H | 1 |
| Ben Amor, F | 1 |
| Bibi, M | 1 |
| Mahjoub, T | 1 |
| Kortas, M | 1 |
| Snoussi, N | 1 |
| Khairi, H | 1 |
| Cohn, GM | 1 |
| Darling, M | 1 |
| Katano, K | 1 |
| Aoyama, T | 1 |
| Suzumori, K | 1 |
| Riyazi, N | 1 |
| Leeda, M | 1 |
| de Vries, JI | 1 |
| Huijgens, PC | 1 |
| van Geijn, HP | 1 |
| Dekker, GA | 1 |
| Ware Branch, D | 1 |
| Hatasaka, HH | 1 |
| Denis, E | 1 |
| Dufour, P | 1 |
| Vinatier, D | 1 |
| Valat, AS | 1 |
| Puech, F | 1 |
| Pfaffenrath, V | 1 |
| Rehm, M | 1 |
| Costa, M | 1 |
| Backos, M | 2 |
| Baxter, N | 1 |
| Chilcott, IT | 1 |
| Murphy, M | 1 |
| Doré, C | 1 |
| Hogg, B | 1 |
| Lindheimer, M | 1 |
| Van Dorsten, JP | 1 |
| Klebanoff, M | 1 |
| MacPherson, C | 1 |
| Landon, M | 1 |
| Paul, R | 1 |
| Miodovnik, M | 1 |
| Meis, PJ | 1 |
| Thurnau, GR | 1 |
| Dombrowski, MP | 1 |
| McNellis, D | 1 |
| Roberts, JM | 1 |
| Vikhliaeva, EM | 1 |
| Le Thi Huong, D | 1 |
| Piette, AM | 1 |
| Young, GL | 1 |
| Sherer, Y | 2 |
| Levy, Y | 2 |
| Uzan, S | 2 |
| Dumont, A | 1 |
| Berkane, N | 1 |
| Beaufils, M | 2 |
| Bréart, G | 2 |
| Bangerter, M | 1 |
| Güthner, C | 1 |
| Beneke, H | 1 |
| Hildebrand, A | 1 |
| Grünewald, M | 1 |
| Griesshammer, M | 1 |
| Pattison, NS | 1 |
| Birdsall, M | 2 |
| Zanderigo, AM | 1 |
| Liddell, HS | 1 |
| McDougall, J | 1 |
| Kruszka, S | 1 |
| Kruszka, P | 1 |
| Sammaritano, LR | 1 |
| Vials, JM | 1 |
| Amsalhem, P | 1 |
| Gaudouen, Y | 1 |
| Krivitzky, A | 1 |
| Font, J | 2 |
| Azulay, M | 1 |
| Creus, M | 1 |
| Fábregues, F | 1 |
| Puerto, B | 1 |
| Werler, MM | 1 |
| Sheehan, JE | 1 |
| Mitchell, AA | 1 |
| Pauzner, R | 1 |
| Dulitzki, M | 2 |
| Langevitz, P | 2 |
| Livneh, A | 2 |
| Kenett, R | 1 |
| Jerzak, MM | 1 |
| Prusek, W | 1 |
| Podwysocka, M | 1 |
| Goluda, M | 1 |
| Adhikari, M | 1 |
| Pillay, T | 1 |
| Nathoo, N | 1 |
| Huskisson, EC | 1 |
| Bulmash, JM | 1 |
| Bove, KE | 1 |
| Bhathena, D | 1 |
| Wyatt, RJ | 2 |
| Lucas, BA | 1 |
| Holland, NH | 1 |
| Mosler, KH | 1 |
| Linka, F | 1 |
| O'Dell, BL | 1 |
| Reynolds, G | 1 |
| Reeves, PG | 1 |
| Read, MD | 1 |
| Lynd, PA | 1 |
| Andreasen, AC | 1 |
| Yaffe, SJ | 1 |
| Tuchmann-Duplessis, H | 1 |
| Pattison, N | 1 |
| Chamley, L | 1 |
| Passaleva, A | 1 |
| Massai, G | 1 |
| D'Elios, MM | 1 |
| Livi, C | 1 |
| Abbate, R | 1 |
| Murray, FE | 1 |
| Cole, AT | 1 |
| Hudson, N | 1 |
| Hawkey, CJ | 1 |
| Ho, HN | 1 |
| Melinda, S | 1 |
| Lin, HH | 1 |
| Hwang, JL | 1 |
| Hsieh, CY | 1 |
| Lee, TY | 1 |
| Ginsberg, JS | 1 |
| Hirsh, J | 1 |
| Blackwell, JL | 1 |
| Reading, JC | 1 |
| Scott, JR | 2 |
| Howell, PR | 1 |
| Douglas, MJ | 1 |
| Takashima, M | 1 |
| Yamasaki, M | 1 |
| Ohashi, M | 1 |
| Morikawa, H | 1 |
| Mochizuki, M | 1 |
| Kobayashi, S | 1 |
| Tamura, N | 1 |
| Tsuda, H | 1 |
| Mokuno, C | 1 |
| Hashimoto, H | 1 |
| Hirose, S | 1 |
| Landy, HJ | 1 |
| Kessler, C | 1 |
| Kelly, WK | 1 |
| Weingold, AB | 1 |
| López-Soto, A | 1 |
| Pallarés, L | 1 |
| Navarro, M | 1 |
| Bosch, X | 1 |
| Ingelmo, M | 1 |
| Cohen, AW | 1 |
| Tikkanen, J | 1 |
| Heinonen, OP | 1 |
| Barton, JR | 1 |
| Baxi, LV | 1 |
| Pearlstone, MM | 1 |
| Keirse, MJ | 1 |
| Seneviratne, HR | 1 |
| Weerasinghe, WM | 1 |
| Shimmyozu, K | 1 |
| Okadome, T | 1 |
| Maruyama, Y | 1 |
| Maruyama, I | 1 |
| Osame, M | 1 |
| Tara, M | 1 |
| de Jong, PC | 1 |
| Zielhuis, GA | 1 |
| Gabreëls, F | 1 |
| Munro, CD | 1 |
| Sumiya, M | 1 |
| Hertz-Picciotto, I | 1 |
| Hopenhayn-Rich, C | 1 |
| Golub, M | 1 |
| Hooper, K | 1 |
| Ordi, J | 1 |
| Barquinero, J | 1 |
| Vilardell, M | 1 |
| Jordana, R | 1 |
| Tolosa, C | 1 |
| Selva, A | 1 |
| Genover, E | 1 |
| Gatenby, PA | 1 |
| Cameron, K | 1 |
| Shearman, RP | 1 |
| Frenkel, Y | 1 |
| Nebel, L | 1 |
| Toder, V | 1 |
| Serr, DM | 1 |
| Howden, CW | 1 |
| Druzin, ML | 1 |
| Qamar, T | 1 |
| Neubert, D | 1 |
| Stahlmann, R | 1 |
| Sautter, RD | 1 |
| Bertelli, A | 1 |
| Silvestrini, B | 1 |
| Kochenour, NK | 1 |
| Hershgold, E | 1 |
| Lee, P | 1 |
| Nakano, J | 1 |
| Nelson, MM | 1 |
| Forfar, JO | 1 |
| Bedi, SS | 1 |
| Marsh, GN | 1 |
| Jewett, JF | 1 |
| Waltman, R | 1 |
| Tricomi, V | 1 |
| Frohberg, H | 1 |
| Presl, J | 1 |
| Mandelcorn, MS | 1 |
| Merin, S | 1 |
| Cardarelli, J | 1 |
| Wajcner, G | 1 |
| Guedon, J | 1 |
| Chapman, A | 1 |
| Rothfield, NF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Implementing Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks - a Randomized Controlled Trial[NCT06108947] | 300 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | |||
| The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
| 162 mg of Aspirin for Prevention of Preeclampsia[NCT05221164] | Phase 4 | 200 participants (Anticipated) | Interventional | 2021-07-06 | Recruiting | ||
| A Randomized Controlled Trial Comparing Low Doses Of Aspirin In The Prevention Of Preeclampsia (ASAPP)[NCT04070573] | Phase 3 | 400 participants (Anticipated) | Interventional | 2019-10-21 | Enrolling by invitation | ||
| Role of Aspirin in Maternal Endothelial Dysfunction and Uterine Artery Blood Flow in Women at Risk for Preeclampsia[NCT03893630] | Phase 2 | 250 participants (Anticipated) | Interventional | 2019-04-25 | Recruiting | ||
| IMPACT - Study for Improving Maternal, Pregnancy and Child Outcomes[NCT03831490] | 13,000 participants (Actual) | Observational [Patient Registry] | 2018-11-09 | Active, not recruiting | |||
| Genetic, Laboratory and Clinical Factors Associated With Low-dose Aspirin Failure in the Prevention of Preeclampsia- An Exploratory Protocol[NCT05709483] | Early Phase 1 | 130 participants (Anticipated) | Interventional | 2023-04-13 | Recruiting | ||
| First-trimester Placental Ultrasound Study (First PLUS): an Observational Cohort Study to Assess the Clinical Utility of the OxNNet Toolkit for the Prediction of Adverse Pregnancy Outcomes.[NCT05326191] | 4,000 participants (Actual) | Observational | 2022-03-15 | Completed | |||
| The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population[NCT05089175] | 4,500 participants (Anticipated) | Observational [Patient Registry] | 2021-11-30 | Recruiting | |||
| A Pragmatic Randomized Study Comparing 81 mg Aspirin Versus 162 mg Aspirin in the Prevention of Preeclampsia During Pregnancy[NCT04158830] | Phase 4 | 0 participants (Actual) | Interventional | 2020-06-01 | Withdrawn (stopped due to PI is no longer at this University.) | ||
| STUDY PROTOCOL FOR A PROSPECTIVE, MULTICENTRE, COHORT STUDY: Preeclampsia Sequential Screening Using Angiogenic Factors During First Trimester of Pregnancy (CRISP STUDY)[NCT04767438] | 6,560 participants (Anticipated) | Observational | 2021-03-31 | Not yet recruiting | |||
| PEPPI Study: Identification of Women at Risk for Placental Dysfunction During the First and Third Trimesters of Pregnancy[NCT06115122] | 3,000 participants (Anticipated) | Observational [Patient Registry] | 2022-02-15 | Recruiting | |||
| Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension: A Pilot Study[NCT04908982] | Phase 4 | 60 participants (Anticipated) | Interventional | 2021-05-28 | Recruiting | ||
| Implementation of First-trimester Screening and Prevention of Preeclampsia: a Stepped Wedge Cluster-randomized Trial in Asia[NCT03941886] | 42,454 participants (Actual) | Interventional | 2019-07-31 | Completed | |||
| Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE): a Randomized Controlled Trial[NCT05253781] | Phase 3 | 476 participants (Anticipated) | Interventional | 2020-07-01 | Recruiting | ||
| Fetal Growth and Placental Function in Pregnancies Complicated by Diabetes[NCT04801121] | 100 participants (Anticipated) | Observational [Patient Registry] | 2020-11-01 | Enrolling by invitation | |||
| First-trimester Preeclampsia Screening: Women's Perspectives[NCT05123560] | 750 participants (Anticipated) | Observational | 2022-04-01 | Not yet recruiting | |||
| Aspirin Versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial[NCT05580523] | 3,000 participants (Anticipated) | Interventional | 2023-07-03 | Recruiting | |||
| Fetal, Obstetrics and Reproduction Genomics[NCT05720169] | 400 participants (Anticipated) | Observational | 2023-10-01 | Not yet recruiting | |||
| Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)[NCT02409680] | 11,976 participants (Actual) | Interventional | 2016-03-23 | Completed | |||
| A Multicenter, Double-blind, Randomized and Parallel Controlled Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Miscarriage With Antiphospholipid Syndrome[NCT04624269] | Phase 4 | 384 participants (Anticipated) | Interventional | 2020-12-01 | Not yet recruiting | ||
| Low-molecular-weight Heparin Versus Unfractionated Heparin in Pregnant Women With History of Recurrent Abortion Secondary to Antiphospholipid Syndrome. A Randomized Controlled Trial[NCT01051778] | Phase 2 | 60 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| Acute Headache Treatment in Pregnancy: Improvement in Pain Scores With Occipital Nerve Block vs PO Acetaminophen With Caffeine A Randomized Controlled Trial[NCT03951649] | Phase 4 | 62 participants (Actual) | Interventional | 2020-02-10 | Completed | ||
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss[NCT04558268] | Phase 2/Phase 3 | 242 participants (Anticipated) | Interventional | 2020-12-31 | Not yet recruiting | ||
| Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 7 |
| Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 374 |
| Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 28 |
| Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 3 |
| Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 4 |
| Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 394 |
| Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
| Intervention | livebirths (Number) |
|---|---|
| Aspirin | 309 |
| Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 0 |
| Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 32 |
| Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 56 |
| Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
| Intervention | infants (Number) |
|---|---|
| Aspirin | 22 |
| Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
| Intervention | grams (Mean) |
|---|---|
| Aspirin | 3327 |
| Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
| Intervention | participants (Number) |
|---|---|
| Aspirin | 2 |
| Placebo | 2 |
- Early preterm delivery (<34 weeks) (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 189 |
| Placebo Arm | 230 |
- Birth weight <2500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1078 |
| Placebo Arm | 1153 |
- Birth weight <1500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 78 |
| Placebo Arm | 101 |
- Incidence of Fetal Loss (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 303 |
| Placebo Arm | 353 |
- Incidence of Spontaneous Abortion (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 134 |
| Placebo Arm | 152 |
- Incidence of All stillbirth (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 141 |
| Placebo Arm | 166 |
- Incidence of Medical Termination of Pregnancy (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 42 |
| Placebo Arm | 30 |
- Hypertensive disorders of pregnancy is defined by the characterization of evidence of a hypertensive disorder, including either preeclampsia or eclampsia occurring during the pregnancy. (NCT02409680)
Timeframe: Evidence of hypertensive disorder during the pregnancy (prior to delivery/birth)
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 352 |
| Placebo Arm | 325 |
- Incidence of Perinatal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 264 |
| Placebo Arm | 309 |
The primary outcome of this study is incidence of preterm birth, which will be defined as delivery at or after 20 0/7 weeks and prior to 37 0/7 weeks. This will be determined based on actual date of delivery in comparison to the projected estimated due date (EDD), independent of whether or not the preterm delivery is indicated or spontaneous. (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 668 |
| Placebo Arm | 754 |
- Small for gestational age (SGA) as defined by the INTERGROWTH-21st standard (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1506 |
| Placebo Arm | 1564 |
- Vaginal bleeding (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 214 |
| Placebo Arm | 246 |
- Antepartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 26 |
| Placebo Arm | 25 |
- Postpartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 54 |
| Placebo Arm | 43 |
- Incidence of Maternal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 9 |
| Placebo Arm | 12 |
- Incidence of Late Abortion (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 23 |
| Placebo Arm | 30 |
Hemoglobin < 7.0 gm/dl at 26-30 weeks gestation or a drop of 3.5+ gm/dl from screening to 26-30 weeks gestation (NCT02409680)
Timeframe: At enrollment, 4 weeks post enrollment, and 26-30 weeks GA.
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 290 |
| Placebo Arm | 333 |
Early preterm delivery (<34 weeks) and hypertensive disorders (i.e.: preeclampsia) (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 8 |
| Placebo Arm | 21 |
Live birth occurs when a fetus (> 24 weeks ) , exits the maternal body and subsequently shows signs of life, such as voluntary movement, heartbeat, or pulsation of the umbilical cord. (NCT01051778)
Timeframe: pregnancy > 24weeks gestation
| Intervention | Percentage of pregnancies (Number) |
|---|---|
| Enoxaparin 40 mg /Day Plus Low Dose Aspirin | 24 |
| Heparin Calcium 5,000 U Twice Daily Plus Low Dose Aspirin | 20 |
(NCT03951649)
Timeframe: 7 days
| Intervention | days (Median) |
|---|---|
| Occipital Nerve Block | 6 |
| Oral Acetaminophen/Caffeine Group | 1 |
(NCT03951649)
Timeframe: 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 9 |
| Oral Acetaminophen/Caffeine Group | 4 |
(NCT03951649)
Timeframe: 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 7 |
| Oral Acetaminophen/Caffeine Group | 2 |
Other: Pain at injection site (NCT03951649)
Timeframe: 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 0 |
| Oral Acetaminophen/Caffeine Group | 2 |
(NCT03951649)
Timeframe: 7 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 0 |
| Oral Acetaminophen/Caffeine Group | 0 |
(NCT03951649)
Timeframe: 4 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 9 |
| Oral Acetaminophen/Caffeine Group | 14 |
(NCT03951649)
Timeframe: 5 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 4 |
| Oral Acetaminophen/Caffeine Group | 2 |
Emergency department for treatment of headache since treatment asked at 28 day follow up (NCT03951649)
Timeframe: 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 5 |
| Oral Acetaminophen/Caffeine Group | 1 |
(NCT03951649)
Timeframe: 120 min
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 5 |
| Oral Acetaminophen/Caffeine Group | 5 |
Based on guidelines from the International Headache Society the primary outcome is the portion of women who experience resolution of headache or improvement of headache to mild range (VRS ≤ 3) at 2 hours following treatment with Occipital nerve block as compared to acetaminophen/caffeine cocktail. (NCT03951649)
Timeframe: 60-300 min
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 20 |
| Oral Acetaminophen/Caffeine Group | 16 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 60 min
| Intervention | score on a scale (Median) |
|---|---|
| Occipital Nerve Block | 6 |
| Oral Acetaminophen/Caffeine Group | 3 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 180min
| Intervention | score on a scale (Median) |
|---|---|
| Occipital Nerve Block | 6 |
| Oral Acetaminophen/Caffeine Group | 4 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 2 hrs
| Intervention | score on a scale (Median) |
|---|---|
| Occipital Nerve Block | 6.0 |
| Oral Acetaminophen/Caffeine Group | 6.5 |
100 reviews available for aspirin and Complications, Pregnancy
| Article | Year |
|---|---|
Impact of subchorionic hematoma on pregnancy outcomes in women with recurrent pregnancy loss.
Topics: Abortion, Habitual; Aspirin; Female; Hematoma; Humans; Pregnancy; Pregnancy Complications; Pregnancy | 2023 |
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.
Topics: Antineoplastic Agents; Aspirin; Birth Rate; Female; Fibrinolytic Agents; Heparin; Humans; Interferon | 2019 |
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Hemorrhage; Humans; Pregnancy; Pregnancy Complications; | 2020 |
Antiphospholipid syndrome: Diagnosis and management in the obstetric patient.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy | 2020 |
Understanding and Preventing Placenta-Mediated Pregnancy Complications.
Topics: Abruptio Placentae; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2020 |
Prevention of preeclampsia with aspirin.
Topics: Aspirin; Cost-Benefit Analysis; Female; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibit | 2022 |
Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Topics: Abortion, Habitual; Abortion, Spontaneous; Anticoagulants; Aspirin; Combined Modality Therapy; Femal | 2021 |
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Ou | 2021 |
Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Ne | 2021 |
Current insights in obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2017 |
The Effects of Aspirin in Gestation and Reproduction (EAGeR) Trial: A Story of Discovery.
Topics: Adolescent; Adult; Aspirin; C-Reactive Protein; Female; Humans; Pregnancy; Pregnancy Complications; | 2017 |
Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review.
Topics: Adult; Aspirin; Cesarean Section; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin, L | 2017 |
Antiphospholipid syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antiph | 2018 |
[Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?]
Topics: Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Pre-Eclampsia; Precision Medicine; Pregnancy | 2018 |
Obstetric Anti-phospholipid Syndrome: State of the Art.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; H | 2018 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; | 2018 |
[Aspirin and preeclampsia].
Topics: Aspirin; Chronobiology Phenomena; Contraindications, Drug; Cyclooxygenase Inhibitors; Drug Utilizati | 2019 |
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
Topics: Adult; Aspirin; Biomarkers; Endoglin; Endothelium, Vascular; Female; Humans; Immune Tolerance; Infla | 2019 |
Treatment and Prevention of Hypertensive Disorders During Pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Chronic Dis | 2019 |
Chronic Kidney Disease and Pregnancy.
Topics: Aspirin; Female; Glomerular Filtration Rate; Humans; Hypertension, Pregnancy-Induced; Infant, Newbor | 2019 |
Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retarda | 2014 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 2. Antiphospholipid syndrome].
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2013 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrin | 2014 |
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Placenta Diseases; Placentation; Pregnanc | 2014 |
Aspirin and heparin in pregnancy.
Topics: Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans; Pregnancy; Pregnancy Complica | 2015 |
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Female; Heparin; H | 2016 |
Pregnancy and Lupus Nephritis.
Topics: Abortion, Spontaneous; Anticoagulants; Antihypertensive Agents; Antiphospholipid Syndrome; Aspirin; | 2015 |
Prevention of Preeclampsia with Aspirin in Multiple Gestations: A Systematic Review and Meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Infant, Small f | 2016 |
[Antiphospholipid syndrome and pregnancy].
Topics: Anticoagulants; Antimalarials; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-We | 2016 |
Pregnancy in women with systemic lupus erythematosus (SLE).
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspi | 2016 |
Ongoing Pharmacological Management of Chronic Pain in Pregnancy.
Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chr | 2016 |
Antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolyt | 2017 |
[Pregnancy and antiphospholipid antibodies].
Topics: Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Complemen | 2008 |
[The antiphospholipid syndrome in the 21st century].
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Tri | 2009 |
[Management of antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Enzyme | 2009 |
Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2010 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Blood Transfus | 2009 |
WITHDRAWN: Antihistamines versus aspirin for itching in late pregnancy.
Topics: Antipruritics; Aspirin; Chlorpheniramine; Female; Histamine H1 Antagonists; Humans; Pregnancy; Pregn | 2010 |
Lupus and pregnancy: integrating clues from the bench and bedside.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Azathioprine; Counseli | 2011 |
Obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Antibody-Dependent Cell Cytotoxicity; Ant | 2012 |
Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Hepari | 2011 |
Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotei | 2012 |
[Developmental toxicity of the over-the-counter analgetics and antypiretics].
Topics: Adult; Analgesics; Antipyretics; Aspirin; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, N | 2012 |
[Antiphospholipid-syndrome - when to treat?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; As | 2012 |
Inherited thrombophilia and gestational vascular complications.
Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; Pregnanc | 2003 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Annexin A5; Antibodies, Anticardiolipin; Anticoagu | 2003 |
Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; | 2003 |
[Factor V Leiden mutation and pregnancy complications].
Topics: Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; Aspirin; Factor V; Fem | 2003 |
Anti-inflammatory pharmacotherapy during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthr | 2004 |
[Migraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategies].
Topics: Abnormalities, Drug-Induced; Acetaminophen; Acupuncture Points; Acupuncture Therapy; Adult; Analgesi | 2003 |
Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Arteries; Aspirin; Female; Fetal Deat | 2004 |
The management of pregnant patients with antiphospholipid syndrome.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pla | 2004 |
Anticoagulation therapy in the antiphospholipid syndrome: recent advances.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Kidney Transplantation; Pregnanc | 2005 |
Obstetrical antiphospholipid syndrome.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Fem | 2006 |
[Acute poisoning: general management and main causes].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Alcoholic Intoxication; Amphetamines; Analgesics; | 2006 |
[Newborn from mother with antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Female; Fet | 2006 |
[Fetus monitoring of a mother suffering from the antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female | 2006 |
The obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; Heparin | 2008 |
[Thromboembolic diseases in pregnancy].
Topics: Algorithms; Anticoagulants; Aspirin; Contraindications; Coumarins; Female; Heparin; Heparin, Low-Mol | 2007 |
Aspirin and reproductive outcomes.
Topics: Abnormalities, Drug-Induced; Antibodies, Antiphospholipid; Aspirin; Cyclooxygenase Inhibitors; Dose- | 2008 |
Pre-pregnancy counselling of patients with vasculitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Contraception; Counseling; Female; | 2008 |
Reciprocal relationship between pregnancy and pulmonary disease. State of the art.
Topics: Adrenergic beta-Agonists; Alcohol Drinking; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Infecti | 1984 |
Systemic lupus erythematosus.
Topics: Abnormalities, Drug-Induced; Abortion, Therapeutic; Adrenal Cortex Hormones; Aspirin; Azathioprine; | 1983 |
Analgesics during pregnancy.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Female; Fetal Death; | 1983 |
[Therapeutic strategy in asthma: special cases and pseudo-asthma].
Topics: Adrenergic beta-Antagonists; Aspirin; Asthma; Asthma, Exercise-Induced; Cardiovascular System; Femal | 1995 |
Drug treatment in pregnancy.
Topics: Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Aspirin; Female; Humans; Magnesium | 1994 |
[Therapeutic management of antiphospholipid antibody syndrome in pregnancy].
Topics: Adrenal Cortex Hormones; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy; Pre | 1993 |
Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes.
Topics: Adult; Aspirin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Humans; Lactation Disorders; | 1994 |
[Antiphospholipid syndrome. Proposition for management].
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Immunoglobulins, Intravenous; Mass Scre | 1993 |
ACOG educational bulletin. Antiphospholipid syndrome. Number 244, February 1998. American College of Obstetricians and Gynecologists.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; H | 1998 |
Antiphospholipid antibodies and infertility: fact or fallacy.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antip | 1998 |
Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 1998 |
[Current obstetrical management of antiphospholipid antibody syndrome: review of the literature apropos of 20 cases].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 1998 |
Migraine in pregnancy: what are the safest treatment options?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Female; Humans; Migraine Disorders; Pregnancy; Pre | 1998 |
[Pharmacological prevention of gestation complications].
Topics: Aspirin; Calcium, Dietary; Fatty Acids, Unsaturated; Female; Humans; Hypertension; Placental Insuffi | 1999 |
[Effect of pregnancy, menopause and hormone substitution therapy on disseminated systemic lupus erythematosus].
Topics: Aspirin; Estrogen Replacement Therapy; Female; Heparin; Humans; Lupus Erythematosus, Systemic; Ovula | 2000 |
[Aspirin and antiphospholipid syndrome].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndrome; Arteriosc | 2000 |
Antihistamines versus aspirin for itching in late pregnancy.
Topics: Antipruritics; Aspirin; Chlorpheniramine; Female; Histamine H1 Antagonists; Humans; Pregnancy; Pregn | 2000 |
[Antiphospholipid antibody syndrome in adverse pregnancy].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; A | 2000 |
Intravenous immunoglobulin therapy of antiphospholipid syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antiph | 2000 |
[Aspirin: a return to the source rather than a big disappointment].
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications | 2000 |
Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
Topics: Aspirin; Female; Humans; MEDLINE; Placebos; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Risk | 2000 |
Update on the management of the pregnant patient with antiphospholipid antibody.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complicatio | 2001 |
A literature review on the antiphospholipid syndrome and the effect on childbearing.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Embolism; Female; Fetal Death; Fetal Diseases; F | 2001 |
Autoimmune factors in assisted reproduction.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Ant | 2002 |
Antiinflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents; Apazone; Arthritis, Rheumatoid; Aspirin; Benzylidene Compounds; Chi | 1977 |
Systemic lupus erythematosus and pregnancy.
Topics: Antimalarials; Aspirin; Autoantibodies; B-Lymphocytes; Complement System Proteins; Female; Glucocort | 1978 |
[Clinical pharmacology in obstetrics: regulation of the uterus].
Topics: Adrenergic beta-Agonists; Aspirin; Ergotamine; Female; Humans; Indomethacin; Methylergonovine; Obste | 1975 |
Use of antithrombotic agents during pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Diseases; Hemorrhage; Humans; Oste | 1992 |
Principles and applications of manipulation of prostaglandin synthesis in pregnancy.
Topics: Aspirin; Diet; Dietary Fats; Epoprostenol; Fatty Acids, Unsaturated; Female; Humans; Indomethacin; P | 1992 |
Prenatal care, screening, and complications.
Topics: alpha-Fetoproteins; Aspirin; Blood Transfusion, Autologous; Female; Humans; Mass Screening; Neural T | 1991 |
Low-dose aspirin to improve perinatal outcome.
Topics: Antibodies; Aspirin; Blood Coagulation Factors; Cardiolipins; Female; Fetal Growth Retardation; Fetu | 1991 |
Antiphospholipid syndrome: laboratory concerns, fetal loss, and pregnancy management.
Topics: Adrenal Cortex Hormones; Aspirin; Autoimmune Diseases; Female; Fetal Death; Heparin; Humans; Phospho | 1991 |
Platelet anti-aggregatory therapy in pregnancy: another role for low dose aspirin?
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; P | 1990 |
The risks and benefits of taking aspirin during pregnancy.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Fetus; Hemorrhage; Humans; Infant, Newborn; P | 1990 |
[Drug prescriptions in pregnancy. Current status].
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; R | 1988 |
Current trends in the research on antiinflammatory agents.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Benzydam | 1985 |
Lupus anticoagulant and pregnancy.
Topics: Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Fetal Death; Fetal Diseases; Fetal Growt | 1985 |
The prostaglandins: their significance in clinical practice.
Topics: Abortion, Induced; Anemia, Hemolytic; Animals; Aspirin; Asthma; Chemical Phenomena; Chemistry; Cycli | 1974 |
[Present position of the toxicology of drugs].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Amantadine; Aminopterin; Animals; Animals, Newbo | 1970 |
43 trials available for aspirin and Complications, Pregnancy
| Article | Year |
|---|---|
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial.
Topics: Adult; Aspirin; Biomarkers; Female; Hemorrhage; Humans; Infant, Newborn; Peripartum Period; Placenta | 2023 |
Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Asymptomatic Diseases; Cohort Studies; Exercise; | 2020 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Maternal Outcomes Associated With Lower Range Stage 1 Hypertension.
Topics: Adolescent; Adult; Aspirin; Female; Fibrinolytic Agents; Humans; Infant, Newborn; Pregnancy; Pregnan | 2018 |
Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes.
Topics: Abortion, Spontaneous; Adult; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug A | 2019 |
Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein.
Topics: Adult; alpha-Fetoproteins; Aspirin; Female; Fetal Death; Humans; Pre-Eclampsia; Pregnancy; Pregnancy | 2014 |
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Low-dose aspirin, smoking status, and the risk of spontaneous preterm birth.
Topics: Adolescent; Adult; Aspirin; Cohort Studies; Double-Blind Method; Female; Humans; Infant, Newborn; In | 2015 |
Rate of Gestational Diabetes Mellitus and Pregnancy Outcomes in Patients with Chronic Hypertension.
Topics: Adult; Aspirin; Diabetes, Gestational; Female; Gestational Age; Humans; Hypertension; Infant, Newbor | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin.
Topics: Adult; Aspirin; Chorionic Gonadotropin; Double-Blind Method; Female; Humans; Pre-Eclampsia; Pregnanc | 2016 |
Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarke | 2016 |
Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes.
Topics: Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Mol | 2017 |
Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Resp | 2009 |
Heparin and aspirin in pregnant Sudanese women with recurrent miscarriage associated with antiphospholipid antibodies.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2007 |
Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2011 |
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
Topics: Antiphospholipid Syndrome; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Gestatio | 2002 |
Antiphospholipid syndrome in pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Double-Blind Method; Female; Gestational Age; He | 2002 |
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Ther | 2003 |
[Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; A | 2003 |
Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dalteparin; Female; Heparin; Humans; Pilo | 2004 |
Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Drug Therapy, Comb | 2005 |
Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Desensitization, Immunologic; Female; Fetal Death; Follow | 2006 |
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.
Topics: Abortion, Habitual; Abortion, Induced; Adult; Anticoagulants; Aspirin; Birth Rate; Birth Weight; Eno | 2006 |
The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels.
Topics: Adolescent; Adult; Aspirin; Birth Weight; Chi-Square Distribution; Chorionic Gonadotropin; Double-Bl | 1995 |
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; F | 1993 |
[Acetylsalicylic acid and kurantil in the prevention of pregnancy complications in glomerulonephritis and hypertension].
Topics: Abortion, Spontaneous; Analysis of Variance; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, C | 1993 |
Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin.
Topics: Adult; Antibodies, Antiphospholipid; Aspirin; Chromatography, High Pressure Liquid; Epoprostenol; Fe | 1993 |
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group.
Topics: Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Follow-Up Studies; Humans; Obs | 1996 |
Neonatal outcome in a randomized, controlled trial of low-dose aspirin in high-risk pregnancies.
Topics: Aspirin; Chronic Disease; Double-Blind Method; Female; Humans; Hypertension; Infant, Newborn; Kidney | 1995 |
Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combinati | 1996 |
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; | 1997 |
Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; He | 1996 |
Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnan | 1997 |
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Autoantibodies; Female; Fetal Membranes, Premature R | 1997 |
Antiphospholipid antibodies and pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Birth Rate; Female; Fetal | 1999 |
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Dru | 1999 |
Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
Topics: Aspirin; Female; Humans; MEDLINE; Placebos; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Risk | 2000 |
Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy | 2000 |
Does antiplatelet therapy prevent preeclampsia and its complications?
Topics: Aspirin; Female; Guidelines as Topic; Humans; Hypertension; Platelet Aggregation Inhibitors; Pre-Ecl | 2001 |
Appropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodies.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndr | 2001 |
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune D | 2001 |
226 other studies available for aspirin and Complications, Pregnancy
| Article | Year |
|---|---|
The Role of the Natural Course in Causal Analysis.
Topics: Adult; Aspirin; Causality; Female; Humans; Models, Theoretical; Pregnancy; Pregnancy Complications; | 2022 |
Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis.
Topics: Aspirin; Female; Humans; Meta-Analysis as Topic; Pre-Eclampsia; Pregnancy; Pregnancy Complications; | 2021 |
Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Hypertension; Length of Stay; Obesity; Pre-Eclampsia; Pr | 2022 |
[Assessment of a teleophthalmology program for the prevention of diabetes blindness in a rural area of Argentina.]
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Ri | 2022 |
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Wei | 2023 |
Comparison of Low Molecular Weight Heparin Used alone or Combined with Aspirin in the Treatment of Fetal Growth Restriction.
Topics: Aspirin; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; I | 2022 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction.
Topics: Arginine; Aspirin; Female; Fetal Growth Retardation; Humans; Maternal Health; Pregnancy; Pregnancy C | 2023 |
Management and outcomes of women with antiphospholipid syndrome during pregnancy.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; | 2023 |
Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Drug | 2019 |
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Live Birth; | 2020 |
Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Drug Dosage | 2020 |
Vital Considerations for Aspirin in Prevention of Preeclampsia, a Multifaceted Pregnancy Disorder.
Topics: Aspirin; Brain; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Trimest | 2020 |
Vital Considerations for Aspirin in Prevention of Preeclampsia, a Multifaceted Pregnancy Disorder-Reply.
Topics: Aspirin; Brain; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Trimest | 2020 |
Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study.
Topics: Adult; Aspirin; Female; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Lupu | 2019 |
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents | 2020 |
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies.
Topics: Adult; Algorithms; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; beta 2-Glycop | 2021 |
Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Vit | 2020 |
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Hy | 2020 |
Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Anticoagulants; A | 2020 |
Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study.
Topics: Abruptio Placentae; Adult; Anticoagulants; Aspirin; Cohort Studies; Female; Gestational Age; Heparin | 2021 |
NETosis Markers in Pregnancy: Effects Differ According to Histone Subtypes.
Topics: Adult; Apoptosis; Aspirin; Cell Line; Cell Movement; Enoxaparin; Extracellular Traps; Female; France | 2021 |
Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Endothelial Cells; | 2022 |
Serological evolution in women with positive antiphospholipid antibodies.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; | 2017 |
Quality measures in high-risk pregnancies: Executive Summary of a Cooperative Workshop of the Society for Maternal-Fetal Medicine, National Institute of Child Health and Human Development, and the American College of Obstetricians and Gynecologists.
Topics: Antibiotic Prophylaxis; Aspirin; Cesarean Section; Congresses as Topic; Female; Fetal Growth Retarda | 2017 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
Topics: Adult; Algorithms; Aspirin; Body Mass Index; Evidence-Based Medicine; Female; Gestational Age; Human | 2017 |
Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Cells, Cult | 2018 |
[Pregnancy outcome in a woman with premature ovarian insufficiency complicated by systemic lupus erythematosus during pregnancy: a case report].
Topics: Aspirin; Cesarean Section; Embryo Transfer; Female; Fertilization in Vitro; Humans; Lupus Erythemato | 2017 |
Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Carrier State; Female; Foll | 2018 |
Postpartum spontaneous renal blood vessel rupture followed by pulmonary artery thromboembolism associated with protein C deficiency.
Topics: Adult; Aspirin; Cesarean Section; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnanc | 2019 |
Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis.
Topics: Adult; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Moscow; Pregnanc | 2018 |
Management of a pregnancy with underlying fibromuscular dysplasia with a history of stroke and carotid artery dissection.
Topics: Adult; Aortic Dissection; Aspirin; Carotid Artery Diseases; Female; Fibromuscular Dysplasia; Humans; | 2019 |
Obstetrical morbidity related to anti-SSA antibodies: Data from a French monocentric retrospective study.
Topics: Adult; Antibodies, Antinuclear; Antiphospholipid Syndrome; Aspirin; Databases, Factual; Female; Fran | 2019 |
[Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 2018 |
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Platelet Agg | 2019 |
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort | 2019 |
Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis.
Topics: Aspirin; Female; Heparin; Humans; Infant, Newborn; Network Meta-Analysis; Pre-Eclampsia; Pregnancy; | 2019 |
Reducing maternal mortality: can elabela help in this fight?
Topics: Age of Onset; Animals; Aspirin; Female; Global Health; Health Promotion; Humans; Maternal Health; Ma | 2019 |
Posterior reversible encephalopathy syndrome, preeclampsia or stroke? A diagnostic dilemma.
Topics: Abdominal Pain; Adrenergic beta-Antagonists; Aspirin; Diagnosis, Differential; Factor V; Female; Hea | 2019 |
Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Fema | 2013 |
Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Case | 2013 |
Anti-phospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Autoimmune Diseases; Female; Humans; Male; Pr | 2014 |
Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle | 2015 |
[Aspirin for migraine in pregnancy. This recommendation seems questionable].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contraindications; Female; Humans; Ibuprofen; Infa | 2013 |
[Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retardation; Heparin | 2014 |
Low-dose aspirin for the prevention of adverse pregnancy outcomes in women with elevated alpha-fetoprotein.
Topics: alpha-Fetoproteins; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications | 2015 |
Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Topics: Abortion, Habitual; Anticoagulants; Apgar Score; Aspirin; Birth Weight; Blood Coagulation Factors; D | 2015 |
Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Drug T | 2015 |
Spontaneous coronary artery dissection in a parturient with Nail-Patella syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antidiuretic | 2015 |
Antecedents and correlates of visual field deficits in children born extremely preterm.
Topics: Acidosis; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cerebral Ventricles; Child Develo | 2015 |
The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension.
Topics: Adult; Amlodipine; Aspirin; Birth Weight; Blood Pressure; Calcium Channel Blockers; China; Female; H | 2015 |
[INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Bulgaria; Female; Heparin; Heparin, Low-Molecula | 2015 |
Use of ticagrelor in human pregnancy, the first experience.
Topics: Adenosine; Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Myocardial Infarction; Platele | 2015 |
Subchorionic hematomas are increased in early pregnancy in women taking low-dose aspirin.
Topics: Adult; Aspirin; Chorion; Cohort Studies; Female; Hematoma; Humans; Middle Aged; Pregnancy; Pregnancy | 2016 |
The participations of the physicians on the diagnosis and treatments of antiphospholipid related pregnancy morbidities in Japan: from the result of nationwide survey.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female | 2015 |
Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Hep | 2016 |
Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy | 2016 |
Stillbirth: the impact of antiphospholipid syndrome?
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Infant, Newborn; Lupus Coagulation Inhi | 2017 |
Vitamin D, pre-eclampsia, and preterm birth among pregnancies at high risk for pre-eclampsia: an analysis of data from a low-dose aspirin trial.
Topics: Adult; Aspirin; Female; Fibrinolytic Agents; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complicatio | 2017 |
Preeclampsia and Preterm Birth Associated With Visceral Adiposity in Early Pregnancy.
Topics: Adult; Aspirin; Body Mass Index; Chronic Disease; Female; Humans; Hypertension; Intra-Abdominal Fat; | 2017 |
Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Placenta; Platelet Aggregation Inhibitors; Preg | 2017 |
Modulation of antiphospholipid antibodies-induced trophoblast damage by different drugs used to prevent pregnancy morbidity associated with antiphospholipid syndrome.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blotting, W | 2017 |
Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2017 |
Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; beta 2-Glyc | 2017 |
Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile.
Topics: Abortion, Spontaneous; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospho | 2017 |
[Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?]
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin; | 2017 |
Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants | 2008 |
[Arterial hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Calcium; Dietary Sup | 2008 |
[Liver infarcts with early HELLP syndrome and probable catastrophic antiphospholipid syndrome].
Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Co | 2009 |
Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin, L | 2008 |
How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
Topics: Algorithms; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female | 2009 |
Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Interferon Type I; Italy; Janus Kinase 2; Middle Aged; M | 2009 |
Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relatio | 2009 |
Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations.
Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Interferon Type I; Pregnancy; P | 2009 |
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Ne | 2010 |
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the HepASA trial.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Clinical Trials as Topic; Female; Gestati | 2010 |
Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury.
Topics: Acetaminophen; Adrenal Cortex Hormones; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Ste | 2010 |
Autoimmunity: effectiveness of treatments for pregnant women with APS.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Autoimmunity; Dose-Re | 2010 |
USPSTF recommendations you may have missed amid the breast cancer controversy.
Topics: Adolescent; Age Factors; Aspirin; Breast Neoplasms; Breast Self-Examination; Child; Depression; Depr | 2010 |
Ultrasonography in pregnant women with antiphospholipid syndrome using salicylic acid and heparin.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans; Infant, Newborn; M | 2011 |
High-dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation; Cesarean Section; Drug Monito | 2010 |
Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; An | 2010 |
Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Chi-Square Distribution; Dru | 2010 |
Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; | 2010 |
Treatment of cobalamin C (cblC) deficiency during pregnancy.
Topics: Amino Acid Metabolism, Inborn Errors; Aspirin; Carnitine; Carrier Proteins; Cells, Cultured; Combine | 2010 |
Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Chest Pain; Dyspnea; Female; Heparin; H | 2011 |
Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Topics: Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; F | 2011 |
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.
Topics: Abortion, Spontaneous; Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Biomarkers; C | 2011 |
Aspirin resistance may be associated with adverse pregnancy outcomes.
Topics: Adult; Aspirin; Cesarean Section; Drug Resistance; Female; Fetal Distress; Humans; Infant, Newborn; | 2011 |
Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function.
Topics: Angiogenic Proteins; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cell Line; Ce | 2011 |
Bloody mess.
Topics: Abortion, Spontaneous; Antibodies, Anticardiolipin; Aspirin; Female; Fibrinolytic Agents; Heparin; H | 2011 |
Bloody tests.
Topics: Abortion, Spontaneous; Antibodies, Anticardiolipin; Aspirin; Female; Fibrinolytic Agents; Hematologi | 2011 |
Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
Topics: Abortion, Spontaneous; Adult; Aspirin; Case-Control Studies; Drug Therapy, Combination; Factor V; Fe | 2012 |
[Successful completed pregnancies in patients with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Azathioprine; Birth Weight; Female; Follow-Up Studies; Gest | 2012 |
Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction.
Topics: Adult; Analgesia, Obstetrical; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Eptifibatide; F | 2012 |
Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-the developmental pattern of neurons in relation to oxidative stress and antioxidant defense system.
Topics: Age Factors; alpha-Tocopherol; Analysis of Variance; Animals; Animals, Newborn; Antioxidants; Ascorb | 2012 |
Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Brain Ische | 2012 |
Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility.
Topics: Abortion, Habitual; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Diabetes, Gestational; Female | 2012 |
Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects.
Topics: Algorithms; Anticoagulants; Aspirin; Body Mass Index; Female; Fetal Death; Fetal Growth Retardation; | 2013 |
Paracetamol use in pregnancy and wheezing in early childhood.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Asthma; Eczema; Female; Humans; Infant; Longitudin | 2002 |
Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Dalteparin; Endothelium, Vascular; F | 2003 |
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Ran | 2003 |
[Current approaches to prevention and treatment of antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Contraceptives, Oral; Enzyme Inhibitors; | 2003 |
[Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Administration Schedule; Female; Fib | 2003 |
Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy.
Topics: Abortion, Spontaneous; Abruptio Placentae; Adult; Antiphospholipid Syndrome; Aspirin; Female; Fetal | 2003 |
Successful perinatal outcome following recurrent idiopathic cerebrovascular strokes in pregnancy: a case report.
Topics: Adult; Aspirin; Cerebral Infarction; Delivery, Obstetric; Diagnosis, Differential; Drug Therapy, Com | 2003 |
[Severe ulcerous hemorrhage after aspirin injection in a pregnant woman].
Topics: Aspirin; Female; Hemorrhage; Humans; Injections; Peptic Ulcer; Peptic Ulcer Hemorrhage; Pregnancy; P | 1957 |
EFFECT OF ACETYLSALICYLIC ACID ON FOETAL RABBITS.
Topics: Abnormalities, Drug-Induced; Aspirin; Female; Fetal Death; Fetus; Humans; Maternal-Fetal Exchange; P | 1964 |
[Prevention of preeclampsia].
Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fetal Diseas | 2003 |
Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Topics: Adult; Aspirin; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Therapy, | 2003 |
[Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Ferric Compounds; F | 2003 |
Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome | 2004 |
Acute fatty liver of pregnancy after aspirin intake.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Component Transfusion; Diagnosis, Dif | 2004 |
Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arteries; Aspirin; Case-Control Studies; Delayed-Act | 2004 |
Splenic infarction in a pregnant woman with systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Aspirin; Cesarean Section; Drug Therap | 2005 |
Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Drug Therapy, Combination; Female; Gestational Age; | 2005 |
Minor physical anomalies are not increased in the offspring of mothers with systemic lupus erythematosus.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Congenital Abnormalities; Fe | 2006 |
High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries.
Topics: Anemia; Anemia, Diamond-Blackfan; Aspirin; Data Collection; Female; France; Germany; Humans; Pregnan | 2006 |
Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Stu | 2006 |
[Recurrent miscarriage and thrombophilia].
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight | 2006 |
[The total antioxidative activity measured by FRAP method in women with intrauterine growth restriction treated by L-arginine].
Topics: Adult; Arginine; Aspirin; Female; Fetal Blood; Fetal Growth Retardation; Humans; Nitric Oxide; Nitri | 2005 |
[Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chorionic Villi; D | 2006 |
A case of stroke in pregnancy: the optimum management of such patients remains a challenge.
Topics: Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; P | 2006 |
[Low dose of aspirin during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Habitual; Abortion, Spontaneous; Adult; Animals; Anti-Inflamm | 2007 |
Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecul | 2007 |
Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma.
Topics: Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Nitric Oxide Donors; Pre-Eclampsia; P | 2007 |
Successful full-term pregnancies with assisted reproduction supported with prednisolone, acetylsalicylic acid and high progesterone doses in a lupus patient.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Inflammatory Agents; Aspirin; Female | 2007 |
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndro | 2008 |
Beta 2-microglobulin and other proteins as parameter for tubular function.
Topics: Acetaminophen; Amino Acid Sequence; Aspirin; beta 2-Microglobulin; Beta-Globulins; Female; Graft Rej | 1981 |
[Azulfidine/Salazopyrin therapy during pregnancy].
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Colitis, Ulcerative; Crohn Disease; Female; Humans; I | 1981 |
Chorea gravidarum associated with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy. Case report.
Topics: Adult; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Female; Humans; Infa | 1983 |
Lupus anticoagulant in pregnancy.
Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Drug Therapy, Combination; | 1984 |
Menorrhagia. A symposium.
Topics: Adolescent; Adult; Aminocaproates; Anti-Inflammatory Agents; Antifibrinolytic Agents; Aspirin; Blood | 1984 |
Premenstrual exacerbation of asthma.
Topics: Adolescent; Adult; Aspirin; Asthma; Contraceptives, Oral; Female; Humans; Menstrual Cycle; Middle Ag | 1984 |
Adult Still's disease associated with pregnancy.
Topics: Adult; Arthritis, Juvenile; Aspirin; Female; Humans; Indomethacin; Prednisone; Pregnancy; Pregnancy | 1980 |
[ASA-triad syndrome in a 21-year-old woman in the 24th week of pregnancy].
Topics: Adult; Aspirin; Asthma; Drug Hypersensitivity; Female; Humans; Nasal Polyps; Pregnancy; Pregnancy Co | 1980 |
[Prostaglandin inhibitors and their use in the obstetrical and gynecological clinic].
Topics: Animals; Aspirin; Ethanol; Female; Fertility; Genital Diseases, Female; Humans; In Vitro Techniques; | 1980 |
Effects of aspirin and related drugs in vitamin E-deficient rats.
Topics: Animals; Aspirin; Blood Cell Count; Female; Fetal Death; Hematocrit; Hemoglobins; Hemolysis; Male; P | 1980 |
A successful pregnancy in a woman with an elevated level of beta 2-glycoprotein I dependent anticardiolipin antibodies, despite a progressive thrombotic condition.
Topics: Adult; Antibodies, Anticardiolipin; Aspirin; beta 2-Glycoprotein I; Enzyme-Linked Immunosorbent Assa | 1995 |
A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus.
Topics: Antibodies, Antiphospholipid; Aspirin; Female; Humans; Lupus Coagulation Inhibitor; Lupus Erythemato | 1995 |
Influence of protein malnutrition on teratogenicity of acetylsalicylic acid in rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Aspirin; Body Weight; Bone and Bones; Ca | 1994 |
Antiphospholipid antibodies and pregnancy wastage.
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 1994 |
High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome.
Topics: Adult; Antibodies, Anti-Idiotypic; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; | 1994 |
Low-dose aspirin in pregnancy: changes in patterns of prescription in The Netherlands.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Netherlands; Pre-Eclampsia; Pregnan | 1993 |
Successful pregnancies in patients with antiphospholipid syndrome treated with low-dose aspirin.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin; Humans; Methy | 1993 |
Course of aPL in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Postpartum Period; | 1993 |
Severe intracranial hemorrhage in a term neonate associated with maternal acetylsalicylic acid ingestion.
Topics: Alcohol Drinking; Aspirin; Cerebral Hemorrhage; Female; Heartburn; Humans; Infant, Newborn; Male; Ma | 1993 |
Antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnan | 1994 |
Hepatic infarction during pregnancy complicated by antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Fetal Death; Humans; Infarction; Liver; Prednisol | 1993 |
Combined corticosteroid and aspirin treatment for the high risk lupus pregnancy.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; | 1993 |
[Retroplacental hematoma and uterine Doppler scan].
Topics: Adult; Aspirin; Birth Weight; Blood Flow Velocity; Diagnosis, Differential; Diastole; Female; Hemato | 1993 |
Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug | 1993 |
Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heparin; | 1993 |
Acetylsalicylic acid inhibits anticardiolipin antibody-induced platelet-activating factor (PAF) synthesis.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Cells, Cultured; Dose-Response Rela | 1993 |
Anticardiolipin syndrome, aspirin therapy and fetal malformation.
Topics: Abnormalities, Drug-Induced; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; | 1993 |
Lupus anticoagulant (LAC) and its relation to pregnancy outcome: a report of five cases.
Topics: Adult; Aspirin; Female; Humans; Lupus Coagulation Inhibitor; Prednisolone; Pregnancy; Pregnancy Comp | 1993 |
Toxic reaction to salicylate in a newborn infant: similarities to neonatal sepsis.
Topics: Aspirin; Diagnosis, Differential; Female; Fetus; Headache; Humans; Infant, Newborn; Infections; Pois | 1993 |
Aspirin, interleukin-3 and the antiphospholipid syndrome.
Topics: Animals; Antiphospholipid Syndrome; Arachidonic Acid; Aspirin; Cyclooxygenase Inhibitors; Female; Hu | 1996 |
Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cocaine; Confounding | 1996 |
Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required.
Topics: Aspirin; Female; Genital Diseases, Female; Humans; Multicenter Studies as Topic; Platelet Aggregatio | 1996 |
Anesthesia with antiphospholipid antibodies: anesthetic management of a parturient with lupus anticoagulant and anticardiolipin antibody.
Topics: Adult; Anesthesia; Anesthesia, Obstetrical; Antibodies; Anticoagulants; Aspirin; Cardiolipins; Femal | 1996 |
Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease.
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Female; Heparin; Humans; Kidney Diseases; Platelet Agg | 1995 |
[The successful therapy of an exacerbation of mesangioproliferative nephritis during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differ | 1995 |
Acetylsalicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy. Are they safe?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; | 1996 |
Antiphospholipid (Hughes') syndrome.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans | 1997 |
[Pregnancy in primary antiphospholipid syndrome. Proposal for a common management protocol].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid S | 1996 |
Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy.
Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; As | 1997 |
Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies.
Topics: Adrenal Cortex Hormones; Aging; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 1997 |
Obstetric outcome in antiphospholipid syndrome.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; | 1997 |
Aspirin treatment of the low-dose-endotoxin-treated pregnant rat: pathophysiologic and immunohistologic aspects.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apyrase; Aspirin; Blood Pressure; Cel | 1997 |
[Recurrent fetal death and antiphospholipid antibody syndrome. A case report].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; | 1997 |
[Primary antiphospholipid syndrome in obstetrics. Apropos of 4 cases with fetal survival].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dipyridamole; D | 1996 |
Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997;25(2):192-196.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Female; Humans; Infant, | 1998 |
Low-dose aspirin not for pre-eclampsia.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Incidence; Placebos; Platelet Activation; Platele | 1998 |
Recurrent abortion and moderate or strong antiphospholipid antibody production.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibo | 1998 |
Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
Topics: Aspirin; Drug Therapy, Combination; Female; Fetal Growth Retardation; Gestational Age; Heparin, Low- | 1998 |
Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study.
Topics: Absorptiometry, Photon; Adult; Antiphospholipid Syndrome; Aspirin; Bone Density; Bone Diseases, Meta | 1999 |
Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Topics: Adult; Anesthesia, Epidural; Aspirin; Cesarean Section; Chronic Disease; Double-Blind Method; Female | 1999 |
Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies.
Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pl | 2000 |
Aspirin to treat obstetric manifestations of the antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Ou | 2001 |
[Atrophic polychondritis and Hashimoto's thyroiditis: apropos of a case].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Follow-Up Studies; Humans; Infant, | 2001 |
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Female; Humans; Multiv | 2001 |
Maternal medication use and risks of gastroschisis and small intestinal atresia.
Topics: Acetaminophen; Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Aspirin; Canada; Ephedrine; Fema | 2002 |
Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Gauche | 2002 |
[Course of pregnancy in a patient with systemic lupus erythematosus--case report].
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Prednisone | 2002 |
Aspirin and trauma--uncommon and preventable causes of intracranial haemorrhage in the newborn.
Topics: Adult; Aspirin; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Int | 2002 |
Diffuse metanephric adenoma after in utero aspirin intoxication. A unique case of progressive renal failure.
Topics: Aspirin; Female; Humans; Infant, Newborn; Kidney Neoplasms; Male; Maternal-Fetal Exchange; Pregnancy | 1979 |
Analogous effects of zinc deficiency and aspirin toxicity in the pregnant rat.
Topics: Aldosterone; Animals; Aspirin; Blood Coagulation; Calcium; Female; Fetal Death; Potassium; Pregnancy | 1977 |
A new hypothesis of itching in pregnancy.
Topics: Aspirin; Chlorpheniramine; Female; Humans; Liver Function Tests; Models, Biological; Pregnancy; Preg | 1977 |
Intrauterine salicylate intoxication in a newborn. A case report.
Topics: Acetazolamide; Aspirin; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Maternal | 1976 |
A clinical look at the problem of drugs in pregnancy and their effect on the fetus.
Topics: Abnormalities, Drug-Induced; Anesthesia, Obstetrical; Aspirin; Drug-Related Side Effects and Adverse | 1975 |
[Influence of acetylsalicylic acid on the course of pregnancy].
Topics: Animals; Aspirin; Cesarean Section; Depression, Chemical; Female; Humans; Infant Mortality; Obstetri | 1975 |
Antiphospholipid antibodies in pregnancy.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Female; Humans; Lupus Coagulation Inhibito | 1992 |
Prevention of miscarriage in antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; | 1992 |
Possible low-dose-aspirin-induced gastropathy.
Topics: Aspirin; Female; Gastric Mucosa; Humans; Pregnancy; Pregnancy Complications; Stomach Diseases | 1992 |
Treatment and outcome of unexplained recurrent spontaneous abortions in subclinical autoimmune disorders.
Topics: Abortion, Habitual; Antibodies, Antinuclear; Aspirin; Autoimmune Diseases; Female; Humans; Infant, N | 1992 |
Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; H | 1992 |
Lupus anticoagulant, paramyotonia congenita and pregnancy.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anesthesia, Epidural; Anesthesia, Obstetrical; A | 1992 |
[A trial of low-dose aspirin therapy in high-risk pregnancy].
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Calcium; Female; Fetal Death; Fetal Growth Retardation; Human | 1992 |
Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.
Topics: Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Cardiolipins; DNA; Female; Humans; Lupus Coag | 1992 |
Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodies.
Topics: Adrenal Cortex Hormones; Adult; Antiphospholipid Syndrome; Aspirin; Cardiolipins; Drug Therapy, Comb | 1992 |
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin | 1991 |
Low-dose aspirin and nulliparae.
Topics: Aspirin; Female; Humans; Hypertension; Parity; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pr | 1991 |
Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring.
Topics: Aspirin; Data Collection; Female; Fever; Finland; Heart Defects, Congenital; Humans; Infant, Newborn | 1991 |
Subchorionic hematomas and the presence of autoantibodies.
Topics: Adult; Aspirin; Autoantibodies; Extraembryonic Membranes; Female; Hematoma; Humans; Prednisone; Preg | 1991 |
[Aspirin and pregnancy].
Topics: Aspirin; Blood Coagulation Factors; Female; Fetal Death; Fetal Growth Retardation; Humans; Hypertens | 1990 |
[Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome].
Topics: Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Drug Therapy, Combination; Female; Fetal Death; | 1990 |
[Aspirin and pregnancy].
Topics: Adolescent; Aspirin; Child; Child Behavior Disorders; Female; Humans; Male; Pregnancy; Pregnancy Com | 1990 |
Women to have more say in births?
Topics: Acetaminophen; Aspirin; Codeine; Female; Humans; Pain; Pregnancy; Pregnancy Complications | 1990 |
[Clinical study and therapy of systemic lupus erythematosus and pregnancy].
Topics: Antibodies, Antinuclear; Aspirin; Female; Heparin; Humans; Infant, Newborn; Kidney Function Tests; L | 1990 |
Fetal loss treatment in patients with antiphospholipid antibodies.
Topics: Abortion, Habitual; Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Humans; Lupus Coagul | 1989 |
Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment.
Topics: Abortion, Spontaneous; Antibodies; Aspirin; Female; Fetal Death; Humans; Lupus Erythematosus, System | 1989 |
Fetal demise associated with lupus anticoagulant: clinical features and results of treatment.
Topics: Adult; Aspirin; Autoantibodies; Blood Coagulation; Dipyridamole; Female; Heparin; Humans; Immunosupp | 1989 |
Treatment of common minor ailments.
Topics: Acetaminophen; Antacids; Antiemetics; Aspirin; Dyspepsia; Female; Heartburn; Histamine H1 Antagonist | 1986 |
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.
Topics: Aspirin; Autoantibodies; Female; Fetal Death; Humans; Lupus Erythematosus, Systemic; Phospholipids; | 1989 |
Etiology and prevention of thromboembolic disease. Taming a complex circulatory malfunction.
Topics: Antithrombin III Deficiency; Aspirin; Blood Coagulation Disorders; Catheters, Indwelling; Contracept | 1986 |
Obstetric complications associated with the lupus anticoagulant.
Topics: Abortion, Spontaneous; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fetal De | 1985 |
Anti-inflammatory therapy during pregnancy and lactation.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Female; Humans; I | 1985 |
Associations between drugs administered during pregnancy and congenital abnormalities of the fetus.
Topics: Abnormalities, Drug-Induced; Adult; Analgesics; Antacids; Antiemetics; Appetite Depressants; Ascorbi | 1971 |
Acute polyarthritis.
Topics: Acute Disease; Arthritis, Rheumatoid; Aspirin; Blood Sedimentation; Diagnosis, Differential; Drainag | 1972 |
Salicylate poisoning.
Topics: Adult; Aspirin; Female; Fetal Death; Humans; Poisoning; Pregnancy; Pregnancy Complications; Salicyla | 1973 |
Letter: Aspirin and pregnancy.
Topics: Animals; Aspirin; Female; Fetus; Humans; Pregnancy; Pregnancy Complications; Rats | 1974 |
[Acylpyrin in gynecology and obstetrics].
Topics: Aspirin; Female; Genital Diseases, Female; Humans; Pregnancy; Pregnancy Complications | 1972 |
Goldenhar's syndrome and phocomelia. Case report and etiologic considerations.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Abortion, Threatened; Aspirin; Caffeine; Child | 1971 |
[Acute anuric renal insufficiency with necrosing arteriolitis. Etiologic problems].
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Angioedema; Anuria; Arteritis; Arthritis; Aspirin; Dr | 1968 |
General considerations in the treatment of systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Allergens; Antimalarials; Aspirin; Contraception; Contraceptives, Oral; Fem | 1969 |